,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2022-03-01 16:55:02,2022-02-28,MYGN,Hart Jayne B.,Chief People Officer,S - Sale+OE,$25.00,-10500,165878,-6%,"-$262,500",,,,,MYGN
1,D,2022-03-01 16:55:02,2022-02-28,MYGN,Hart Jayne B.,Chief People Officer,M - OptEx,$23.98,10500,165878,+7%,"+$251,790",,,,,MYGN
2,,2022-02-28 17:02:15,2022-02-25,MYGN,Haas Kevin Richard,CTO,F - Tax,$24.69,-865,71828,-1%,"-$21,357",,,,,MYGN
3,,2022-02-28 16:58:21,2022-02-25,MYGN,Ancona Margaret,See Remarks,F - Tax,$24.69,-2594,27406,-9%,"-$64,046",,,,,MYGN
4,,2022-02-18 17:39:52,2022-02-18,MYGN,Riggsbee Richard Bryan,CFO,F - Tax,$25.69,-11180,393594,-3%,"-$287,214",,,,,MYGN
5,,2022-02-18 17:39:52,2022-02-16,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,48009,393594,+14%,+$0,,,,,MYGN
6,,2022-02-18 17:26:51,2022-02-16,MYGN,Wong Pamela,GC,A - Grant,$0.00,23072,38825,+146%,+$0,,,,,MYGN
7,,2022-02-18 17:24:12,2022-02-16,MYGN,Santa Eric,Chief Growth Officer,A - Grant,$0.00,24052,40472,+146%,+$0,,,,,MYGN
8,,2022-02-18 17:19:43,2022-02-16,MYGN,Haas Kevin Richard,CTO,A - Grant,$0.00,19520,72693,+37%,+$0,,,,,MYGN
9,,2022-02-18 17:16:48,2022-02-16,MYGN,Hart Jayne B.,Chief People Officer,A - Grant,$0.00,19520,165878,+13%,+$0,,,,,MYGN
10,,2022-02-18 17:14:09,2022-02-16,MYGN,Lambert Nicole,COO,A - Grant,$0.00,43295,217781,+25%,+$0,,,,,MYGN
11,,2022-02-18 17:11:14,2022-02-16,MYGN,Verratti Mark,"Pres, Mental Health",A - Grant,$0.00,22616,216635,+12%,+$0,,,,,MYGN
12,,2022-02-18 16:16:30,2022-02-16,MYGN,Diaz Paul J,"Pres, CEO",A - Grant,$0.00,234271,1030369,+29%,+$0,,,,,MYGN
13,,2021-12-10 16:39:47,2021-12-08,MYGN,Lambert Nicole,See Remarks,A - Grant,$0.00,10000,174486,+6%,+$0,,,,,MYGN
14,,2021-12-01 18:19:37,2021-11-30,MYGN,Hart Jayne B.,Chief People Officer,A - Grant,$21.98,143,146358,0%,"+$3,143",,,,,MYGN
15,,2021-10-18 19:16:26,2021-10-18,MYGN,Wong Pamela,GC,A - Grant,$0.00,15753,15753,New,+$0,,,,,MYGN
16,,2021-10-12 16:55:55,2021-10-09,MYGN,Verratti Mark,"Pres, Myriad Neuroscience",F - Tax,$30.88,-8340,194019,-4%,"-$257,539",,,,,MYGN
17,,2021-10-12 16:52:57,2021-10-09,MYGN,Riggsbee Richard Bryan,CFO,F - Tax,$30.88,-12398,356765,-3%,"-$382,850",,,,,MYGN
18,,2021-10-12 16:49:46,2021-10-09,MYGN,Lanchbury Jerry S,Chief Scientific Officer,F - Tax,$30.88,-10811,264324,-4%,"-$333,844",,,,,MYGN
19,,2021-10-12 16:46:00,2021-10-09,MYGN,Lambert Nicole,See Remarks,F - Tax,$30.88,-12483,164169,-7%,"-$385,475",,,,,MYGN
20,,2021-10-12 16:42:56,2021-10-09,MYGN,Hart Jayne B.,Chief People Officer,F - Tax,$30.88,-4926,146215,-3%,"-$152,115",,,,,MYGN
21,,2021-10-12 16:39:08,2021-10-09,MYGN,Haas Kevin Richard,CTO,F - Tax,$30.88,-1729,53173,-3%,"-$53,392",,,,,MYGN
22,,2021-10-04 16:16:45,2021-10-01,MYGN,Lambert Nicole,See Remarks,S - Sale,$31.57,-1420,176652,-1%,"-$44,835",,,,,MYGN
23,,2021-09-27 21:13:55,2021-09-27,MYGN,Lambert Nicole,See Remarks,S - Sale,$33.10,-10112,178072,-5%,"-$334,747",,,,,MYGN
24,M,2021-09-27 21:13:55,2021-09-25,MYGN,Lambert Nicole,See Remarks,F - Tax,$33.31,-4737,178072,-3%,"-$157,789",,,,,MYGN
25,M,2021-09-27 21:12:04,2021-09-25,MYGN,Verratti Mark,"Pres, Myriad Neuroscience",F - Tax,$33.31,-10260,202359,-5%,"-$341,761",,,,,MYGN
26,M,2021-09-27 19:54:44,2021-09-25,MYGN,Haas Kevin Richard,CTO,F - Tax,$33.31,-1211,54902,-2%,"-$40,338",,,,,MYGN
27,M,2021-09-27 19:48:23,2021-09-25,MYGN,Hart Jayne B.,Chief People Officer,F - Tax,$33.31,-6094,110120,-5%,"-$202,991",,,,,MYGN
28,,2021-09-27 19:40:18,2021-09-23,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale,$35.06,-200,275135,0%,"-$7,012",,,,,MYGN
29,M,2021-09-27 19:40:18,2021-09-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,F - Tax,$33.31,-13380,275135,-5%,"-$445,688",,,,,MYGN
30,,2021-09-27 19:39:33,2021-09-23,MYGN,Diaz Paul J,"Pres, CEO",F - Tax,$34.76,-49390,796098,-6%,"-$1,716,796",,,,,MYGN
31,,2021-09-27 19:39:33,2021-09-23,MYGN,Diaz Paul J,"Pres, CEO",A - Grant,$0.00,445439,796098,+127%,+$0,,,,,MYGN
32,M,2021-09-27 19:33:59,2021-09-25,MYGN,Riggsbee Richard Bryan,CFO,F - Tax,$33.31,-16448,369163,-4%,"-$547,883",,,,,MYGN
33,,2021-09-23 17:26:41,2021-09-21,MYGN,Hart Jayne B.,Chief People Officer,A - Grant,$0.00,26598,116214,+30%,+$0,,,,,MYGN
34,,2021-09-23 17:24:40,2021-09-21,MYGN,Lambert Nicole,See Remarks,A - Grant,$0.00,65870,192921,+52%,+$0,,,,,MYGN
35,,2021-09-23 17:22:28,2021-09-21,MYGN,Verratti Mark,"Pres, Myriad Neuroscience",A - Grant,$0.00,56571,212619,+36%,+$0,,,,,MYGN
36,,2021-09-23 17:20:15,2021-09-21,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,58398,288715,+25%,+$0,,,,,MYGN
37,,2021-09-23 17:17:37,2021-09-21,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,66977,385611,+21%,+$0,,,,,MYGN
38,D,2021-09-21 18:18:42,2021-09-17,MYGN,Hart Jayne B.,Chief People Officer,S - Sale+OE,$33.72,-67446,89616,-43%,"-$2,274,279",,,,,MYGN
39,D,2021-09-21 18:18:42,2021-09-17,MYGN,Hart Jayne B.,Chief People Officer,M - OptEx,$26.49,77000,89616,+610%,"+$2,039,730",,,,,MYGN
40,,2021-08-30 16:11:46,2021-08-27,MYGN,Lambert Nicole,See Remarks,S - Sale,$34.50,-945,127051,-1%,"-$32,603",,,,,MYGN
41,,2021-08-26 21:58:09,2021-08-25,MYGN,Hart Jayne B.,Chief People Officer,F - Tax,$34.81,-1148,80062,-1%,"-$39,962",,,,,MYGN
42,,2021-08-26 21:55:59,2021-08-25,MYGN,Lambert Nicole,See Remarks,F - Tax,$34.81,-1123,127996,-1%,"-$39,092",,,,,MYGN
43,,2021-08-26 21:55:10,2021-08-25,MYGN,Verratti Mark,"Pres, Myriad Neuroscience",F - Tax,$34.81,-1082,156048,-1%,"-$37,664",,,,,MYGN
44,,2021-08-26 21:54:20,2021-08-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,F - Tax,$34.81,-2233,230317,-1%,"-$77,731",,,,,MYGN
45,,2021-08-26 21:53:47,2021-08-10,MYGN,Riggsbee Richard Bryan,CFO,G - Gift,$0.00,-3250,318634,-1%,-$0,,,,,MYGN
46,,2021-08-26 21:53:47,2021-08-25,MYGN,Riggsbee Richard Bryan,CFO,F - Tax,$34.81,-3058,318634,-1%,"-$106,449",,,,,MYGN
47,DM,2021-08-25 20:32:59,2021-08-23,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$35.32,-80000,232550,-26%,"-$2,825,600",,,,,MYGN
48,DM,2021-08-25 20:32:59,2021-08-23,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$27.07,80000,232550,+52%,"+$2,165,600",,,,,MYGN
49,,2021-08-16 19:08:25,2021-08-13,MYGN,Diaz Paul J,"Pres, CEO",F - Tax,$32.79,-58820,400049,-13%,"-$1,928,708",,,,,MYGN
50,D,2021-08-06 17:47:27,2021-08-05,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$35.57,-28225,232550,-11%,"-$1,004,008",,,,,MYGN
51,D,2021-08-06 17:47:27,2021-08-05,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$27.07,28225,232550,+14%,"+$764,051",,,,,MYGN
52,D,2021-08-06 17:43:52,2021-08-05,MYGN,Phanstiel S. Louise,Dir,S - Sale+OE,$35.04,-47881,112646,-30%,"-$1,677,741",,,,,MYGN
53,D,2021-08-06 17:43:52,2021-08-05,MYGN,Phanstiel S. Louise,Dir,M - OptEx,$23.34,60000,112646,+114%,"+$1,400,400",,,,,MYGN
54,,2021-08-05 17:23:30,2021-08-03,MYGN,Riggsbee Richard Bryan,CFO,S - Sale,$35.14,-14983,324942,-4%,"-$526,476",,,,,MYGN
55,DM,2021-08-05 17:18:01,2021-08-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$34.68,-100000,232550,-30%,"-$3,467,764",,,,,MYGN
56,DM,2021-08-05 17:18:01,2021-08-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$25.99,100000,232550,+75%,"+$2,598,710",,,,,MYGN
57,D,2021-08-05 17:11:17,2021-08-03,MYGN,Langer Dennis,Dir,S - Sale+OE,$34.75,-30000,89527,-25%,"-$1,042,500",,,,,MYGN
58,D,2021-08-05 17:11:17,2021-08-03,MYGN,Langer Dennis,Dir,M - OptEx,$25.39,30000,89527,+50%,"+$761,700",,,,,MYGN
59,DM,2021-07-14 17:44:33,2021-07-12,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$33.64,-93295,232550,-29%,"-$3,138,273",,,,,MYGN
60,DM,2021-07-14 17:44:33,2021-07-12,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$26.49,93295,232550,+67%,"+$2,471,385",,,,,MYGN
61,D,2021-07-12 18:16:38,2021-07-09,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$32.62,-50000,232550,-18%,"-$1,631,037",,,,,MYGN
62,D,2021-07-12 18:16:38,2021-07-09,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$24.01,50000,232550,+27%,"+$1,200,302",,,,,MYGN
63,D,2021-07-08 17:50:44,2021-07-07,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$32.27,-32308,232550,-12%,"-$1,042,660",,,,,MYGN
64,D,2021-07-08 17:50:44,2021-07-07,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$26.49,32308,232550,+16%,"+$855,839",,,,,MYGN
65,D,2021-06-30 17:50:20,2021-06-28,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$25.51,6812,232550,+3%,"+$173,795",,,,,MYGN
66,D,2021-06-30 17:50:20,2021-06-28,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$32.39,-6812,232550,-3%,"-$220,608",,,,,MYGN
67,D,2021-06-28 20:00:59,2021-06-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$31.96,-83372,232550,-26%,"-$2,664,216",,,,,MYGN
68,D,2021-06-28 20:00:59,2021-06-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$19.47,50000,232550,+27%,"+$973,500",,,,,MYGN
69,,2021-06-17 17:41:51,2021-06-17,MYGN,Spiegelman Daniel K,Dir,S - Sale,$30.52,-3139,23129,-12%,"-$95,795",,,,,MYGN
70,,2021-06-04 20:34:16,2021-06-03,MYGN,Skovronsky Daniel,Dir,A - Grant,$0.00,12848,37889,+51%,+$0,,,,,MYGN
71,,2021-06-04 19:43:36,2021-06-03,MYGN,Reitan Colleen F,Dir,A - Grant,$0.00,12848,40424,+47%,+$0,,,,,MYGN
72,,2021-06-04 19:39:12,2021-06-03,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,12848,100527,+15%,+$0,,,,,MYGN
73,,2021-06-04 19:14:44,2021-06-03,MYGN,Kumar Rashmi,Dir,A - Grant,$0.00,12848,36771,+54%,+$0,,,,,MYGN
74,,2021-06-04 19:11:07,2021-06-03,MYGN,Spiegelman Daniel K,Dir,A - Grant,$0.00,12848,26268,+96%,+$0,,,,,MYGN
75,,2021-06-04 19:02:42,2021-06-03,MYGN,Newcomer Lee Nisley,Dir,A - Grant,$0.00,12848,40424,+47%,+$0,,,,,MYGN
76,,2021-06-04 18:58:35,2021-06-03,MYGN,Langer Dennis,Dir,A - Grant,$0.00,12848,89527,+17%,+$0,,,,,MYGN
77,,2021-06-04 18:55:15,2021-06-03,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,12848,83527,+18%,+$0,,,,,MYGN
78,,2021-06-03 18:45:34,2021-05-28,MYGN,Hart Jayne B.,Chief People Officer,A - Grant,$15.86,1082,81210,+1%,"+$17,162",,,,,MYGN
79,,2021-06-03 18:42:10,2021-05-28,MYGN,Haas Kevin Richard,CTO,A - Grant,$15.86,344,56113,+1%,"+$5,456",,,,,MYGN
80,,2021-06-01 19:15:40,2021-05-28,MYGN,Spiegelman Daniel K,Dir,S - Sale,$28.99,-7142,13420,-35%,"-$207,023",,,,,MYGN
81,,2021-05-28 18:48:14,2021-05-27,MYGN,Spiegelman Daniel K,Dir,D - Sale to issuer,$0.00,-15889,20562,-44%,-$0,,,,,MYGN
82,D,2021-05-05 19:45:58,2021-05-04,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$31.97,-19360,265922,-7%,"-$618,949",,,,,MYGN
83,D,2021-05-05 19:45:58,2021-05-04,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$19.47,19360,265922,+8%,"+$376,939",,,,,MYGN
84,D,2021-04-28 17:10:33,2021-04-27,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$31.47,-40000,265922,-13%,"-$1,258,800",,,,,MYGN
85,D,2021-04-28 17:10:33,2021-04-27,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$19.47,40000,265922,+18%,"+$778,800",,,,,MYGN
86,,2021-04-20 17:18:30,2021-04-19,MYGN,Lambert Nicole,See Remarks,S - Sale,$27.01,-6649,129119,-5%,"-$179,586",,,,,MYGN
87,,2021-04-02 11:23:45,2021-04-01,MYGN,Santa Eric,Chief Growth Officer,A - Grant,$0.00,16420,16420,New,+$0,,,,,MYGN
88,D,2021-03-30 18:31:03,2021-03-29,MYGN,Hart Jayne B.,Chief People Officer,S - Sale+OE,$30.00,-58000,80128,-42%,"-$1,740,000",,,,,MYGN
89,D,2021-03-30 18:31:03,2021-03-29,MYGN,Hart Jayne B.,Chief People Officer,M - OptEx,$22.27,58000,80128,+262%,"+$1,291,860",,,,,MYGN
90,,2021-03-26 17:22:40,2021-03-24,MYGN,Diaz Paul J,"Pres, CEO",A - Grant,$0.00,159915,458869,+53%,+$0,,,,,MYGN
91,,2021-03-26 16:45:40,2021-03-24,MYGN,Hart Jayne B.,Chief People Officer,A - Grant,$0.00,13326,80128,+20%,+$0,,,,,MYGN
92,,2021-03-26 16:41:07,2021-03-24,MYGN,Jackson Benjamin,"E.VP, GC",A - Grant,$0.00,18879,107029,+21%,+$0,,,,,MYGN
93,,2021-03-26 16:37:37,2021-03-24,MYGN,Parkinson Paul,"EVP Strategy, Innovation",A - Grant,$0.00,10661,87407,+14%,+$0,,,,,MYGN
94,,2021-03-26 16:33:58,2021-03-24,MYGN,Haas Kevin Richard,CTO,A - Grant,$0.00,13326,55769,+31%,+$0,,,,,MYGN
95,,2021-03-26 16:30:01,2021-03-24,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,19347,265922,+8%,+$0,,,,,MYGN
96,,2021-03-26 16:23:28,2021-03-24,MYGN,Verratti Mark,"Pres, Myriad Neuroscience",A - Grant,$0.00,15441,157130,+11%,+$0,,,,,MYGN
97,,2021-03-26 16:19:52,2021-03-24,MYGN,Lambert Nicole,"Pres, Myriad Oncology,",A - Grant,$0.00,29556,135768,+28%,+$0,,,,,MYGN
98,,2021-03-26 16:15:46,2021-03-24,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,32774,339925,+11%,+$0,,,,,MYGN
99,,2021-02-22 16:46:00,2021-02-18,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$29.69,-11175,307151,-4%,"-$331,786",,,,,MYGN
100,,2021-02-22 16:43:43,2021-02-18,MYGN,Ancona Margaret,SVP Enterprise Transformation,A - Grant,$0.00,30000,30000,New,+$0,,,,,MYGN
101,,2021-02-22 16:38:27,2021-02-18,MYGN,Haas Kevin Richard,SVP Technology,A - Grant,$0.00,10000,42443,+31%,+$0,,,,,MYGN
102,D,2021-02-17 18:10:02,2021-02-16,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$18.00,80000,246575,+48%,"+$1,440,000",,,,,MYGN
103,D,2021-02-17 18:10:02,2021-02-16,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$29.71,-80000,246575,-24%,"-$2,377,048",,,,,MYGN
104,,2021-01-11 16:40:13,2021-01-08,MYGN,Parkinson Paul,"EVP Strategy, Innovation",S - Sale,$25.00,-11824,76746,-13%,"-$295,600",,,,,MYGN
105,,2020-12-07 18:44:08,2020-12-04,MYGN,Reitan Colleen F,Dir,A - Grant,$0.00,15889,27576,+136%,+$0,,,,,MYGN
106,,2020-12-07 18:41:24,2020-12-04,MYGN,Skovronsky Daniel,Dir,A - Grant,$0.00,15889,40930,+63%,+$0,,,,,MYGN
107,,2020-12-07 17:27:07,2020-12-04,MYGN,Spiegelman Daniel K,Dir,A - Grant,$0.00,15889,36451,+77%,+$0,,,,,MYGN
108,,2020-12-07 17:24:06,2020-12-04,MYGN,Newcomer Lee Nisley,Dir,A - Grant,$0.00,15889,27576,+136%,+$0,,,,,MYGN
109,,2020-12-07 17:14:38,2020-12-04,MYGN,Langer Dennis,Dir,A - Grant,$0.00,15889,76679,+26%,+$0,,,,,MYGN
110,,2020-12-07 17:11:47,2020-12-04,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,15889,70679,+29%,+$0,,,,,MYGN
111,,2020-12-07 17:09:21,2020-12-04,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,15889,87679,+22%,+$0,,,,,MYGN
112,,2020-11-12 08:57:34,2020-11-11,MYGN,Phanstiel S. Louise,Dir,P - Purchase,$16.62,15000,71790,+26%,"+$249,336",,,,,MYGN
113,,2020-11-02 21:22:06,2020-10-31,MYGN,Parkinson Paul,"EVP Strategy, Innovation",D - Sale to issuer,$12.43,-2218,88570,-2%,"-$27,570",,,,,MYGN
114,,2020-10-13 08:21:28,2020-10-08,MYGN,Hart Jayne B.,EVP HR,A - Grant,$0.00,17853,66802,+36%,+$0,,,,,MYGN
115,,2020-10-13 08:19:33,2020-10-08,MYGN,Parkinson Paul,"EVP Strategy, Innovation",A - Grant,$0.00,21730,90788,+31%,+$0,,,,,MYGN
116,,2020-10-13 08:17:42,2020-10-08,MYGN,Jackson Benjamin,"E.VP, GC",A - Grant,$0.00,29784,88150,+51%,+$0,,,,,MYGN
117,,2020-10-13 08:14:41,2020-10-08,MYGN,Lambert Nicole,"Pres, MGL",A - Grant,$0.00,44211,106212,+71%,+$0,,,,,MYGN
118,,2020-10-13 08:11:04,2020-10-08,MYGN,Verratti Mark,Pres Assurex Health Inc.,A - Grant,$0.00,31258,141689,+28%,+$0,,,,,MYGN
119,,2020-10-13 08:06:14,2020-10-08,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,39196,246575,+19%,+$0,,,,,MYGN
120,,2020-10-13 08:02:11,2020-10-08,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,44954,318326,+16%,+$0,,,,,MYGN
121,,2020-10-01 17:43:00,2020-09-30,MYGN,Hart Jayne B.,EVP HR,D - Sale to issuer,$13.04,-2218,48949,-4%,"-$28,923",,,,,MYGN
122,,2020-10-01 17:40:31,2020-09-30,MYGN,Jackson Benjamin,"E.VP, GC",D - Sale to issuer,$13.04,-416,58366,-1%,"-$5,425",,,,,MYGN
123,,2020-10-01 17:38:14,2020-09-30,MYGN,Lambert Nicole,"Pres, MGL",D - Sale to issuer,$13.04,-591,62001,-1%,"-$7,707",,,,,MYGN
124,,2020-10-01 17:35:43,2020-09-30,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$13.04,-725,110431,-1%,"-$9,454",,,,,MYGN
125,,2020-10-01 17:32:45,2020-09-30,MYGN,Ford Alexander,COO,D - Sale to issuer,$13.04,-6653,169040,-4%,"-$86,755",,,,,MYGN
126,,2020-10-01 17:30:24,2020-09-30,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$13.04,-5544,207379,-3%,"-$72,294",,,,,MYGN
127,,2020-10-01 17:27:36,2020-09-30,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$13.04,-6653,273372,-2%,"-$86,755",,,,,MYGN
128,M,2020-09-28 13:15:35,2020-09-25,MYGN,Hart Jayne B.,EVP HR,D - Sale to issuer,$12.44,-6100,51167,-11%,"-$75,884",,,,,MYGN
129,M,2020-09-28 13:10:16,2020-09-25,MYGN,Parkinson Paul,"EVP Strategy, Innovation",D - Sale to issuer,$12.44,-7763,69058,-10%,"-$96,572",,,,,MYGN
130,M,2020-09-28 13:06:44,2020-09-25,MYGN,Jackson Benjamin,"E.VP, GC",D - Sale to issuer,$12.44,-3755,58782,-6%,"-$46,712",,,,,MYGN
131,M,2020-09-28 12:59:16,2020-09-25,MYGN,Lambert Nicole,"Pres, MGL",D - Sale to issuer,$12.44,-4204,62592,-6%,"-$52,298",,,,,MYGN
132,,2020-09-28 12:55:34,2020-09-24,MYGN,Verratti Mark,Pres Assurex Health Inc.,A - Grant,$0.00,32800,111156,+42%,+$0,,,,,MYGN
133,M,2020-09-28 12:55:34,2020-09-25,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$12.44,-8170,111156,-7%,"-$101,635",,,,,MYGN
134,,2020-09-28 12:52:12,2020-09-24,MYGN,Ford Alexander,COO,A - Grant,$0.00,41000,175693,+30%,+$0,,,,,MYGN
135,M,2020-09-28 12:52:12,2020-09-25,MYGN,Ford Alexander,COO,D - Sale to issuer,$12.44,-16466,175693,-9%,"-$204,837",,,,,MYGN
136,,2020-09-28 12:47:26,2020-09-24,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,32800,212923,+18%,+$0,,,,,MYGN
137,M,2020-09-28 12:47:26,2020-09-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$12.44,-13385,212923,-6%,"-$166,509",,,,,MYGN
138,,2020-09-28 12:42:38,2020-09-24,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,41000,280025,+17%,+$0,,,,,MYGN
139,M,2020-09-28 12:42:38,2020-09-25,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$12.44,-16466,280025,-6%,"-$204,837",,,,,MYGN
140,,2020-09-18 11:29:38,2020-09-17,MYGN,Kumar Rashmi,Dir,A - Grant,$0.00,23923,23923,New,+$0,,,,,MYGN
141,,2020-09-16 09:56:04,2020-09-15,MYGN,Ford Alexander,COO,S - Sale,$13.78,-2804,151159,-2%,"-$38,630",,,,,MYGN
142,,2020-08-17 16:36:00,2020-08-12,MYGN,Jackson Benjamin,"E.VP, GC",A - Grant,$0.00,6541,62537,+12%,+$0,,,,,MYGN
143,,2020-08-17 16:33:02,2020-08-12,MYGN,Lambert Nicole,"Pres, MGL",A - Grant,$0.00,7646,66796,+13%,+$0,,,,,MYGN
144,,2020-08-17 16:29:27,2020-08-12,MYGN,Verratti Mark,Pres Assurex Health Inc.,A - Grant,$0.00,7467,86526,+9%,+$0,,,,,MYGN
145,,2020-08-17 16:25:30,2020-08-12,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,10068,193508,+5%,+$0,,,,,MYGN
146,,2020-08-17 16:21:05,2020-08-12,MYGN,Ford Alexander,"Pres, MWH",A - Grant,$0.00,11525,153963,+8%,+$0,,,,,MYGN
147,,2020-08-17 16:12:14,2020-08-12,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,13787,255491,+6%,+$0,,,,,MYGN
148,D,2020-08-14 18:08:47,2020-08-13,MYGN,Diaz Paul J,"Pres, CEO",A - Grant,$0.00,298954,298954,New,+$0,,,,,MYGN
149,,2020-07-23 10:44:31,2020-07-21,MYGN,Skovronsky Daniel,Dir,A - Grant,$0.00,25041,25041,New,+$0,,,,,MYGN
150,,2020-05-28 11:17:08,2020-05-27,MYGN,Spiegelman Daniel K,Dir,A - Grant,$0.00,20562,20562,New,+$0,,,,,MYGN
151,,2020-02-20 18:34:21,2020-02-18,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,100000,244204,+69%,+$0,,,,,MYGN
152,,2020-02-12 18:28:50,2020-02-12,MYGN,Lambert Nicole,"Pres, MGL",S - Sale,$19.73,-4354,59150,-7%,"-$85,915",,,,,MYGN
153,,2020-02-07 14:39:19,2020-02-05,MYGN,Ford Alexander,"Pres, MWH",S - Sale,$30.00,-7273,142438,-5%,"-$218,190",,,,,MYGN
154,D,2019-12-27 12:47:19,2019-12-26,MYGN,Ford Alexander,"Pres, MWH",M - OptEx,$15.98,1307,149711,+1%,"+$20,886",,,,,MYGN
155,,2019-12-16 16:16:55,2019-12-13,MYGN,Gilbert Walter Phd,Dir,P - Purchase,$25.60,5860,54150,+12%,"+$149,998",,,,,MYGN
156,,2019-12-06 15:25:25,2019-12-05,MYGN,Reitan Colleen F,Dir,A - Grant,$0.00,11687,11687,New,+$0,,,,,MYGN
157,,2019-12-06 13:57:45,2019-12-05,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,11687,56790,+26%,+$0,,,,,MYGN
158,,2019-12-06 13:25:42,2019-12-05,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,11687,48290,+32%,+$0,,,,,MYGN
159,,2019-12-06 13:19:09,2019-12-05,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,11687,60790,+24%,+$0,,,,,MYGN
160,,2019-12-06 13:17:50,2019-12-05,MYGN,Newcomer Lee Nisley,Dir,A - Grant,$0.00,11687,11687,New,+$0,,,,,MYGN
161,,2019-12-06 13:15:41,2019-12-05,MYGN,Langer Dennis,Dir,A - Grant,$0.00,11687,60790,+24%,+$0,,,,,MYGN
162,,2019-12-06 13:14:02,2019-12-05,MYGN,Henderson John T,Dir,A - Grant,$0.00,11687,78090,+18%,+$0,,,,,MYGN
163,,2019-12-06 13:10:45,2019-12-05,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,11687,54790,+27%,+$0,,,,,MYGN
164,,2019-11-07 13:05:29,2019-11-07,MYGN,Henderson John T,Dir,P - Purchase,$23.46,7000,66403,+12%,"+$164,223",,,,,MYGN
165,,2019-10-01 21:02:42,2019-09-30,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$28.63,-7153,148397,-5%,"-$204,790",,,,,MYGN
166,,2019-10-01 18:50:16,2019-09-30,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$28.63,-11942,144204,-8%,"-$341,899",,,,,MYGN
167,,2019-10-01 18:45:04,2019-09-30,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$28.63,-11107,160636,-6%,"-$317,993",,,,,MYGN
168,,2019-10-01 18:43:04,2019-09-30,MYGN,Jackson Benjamin,"E.VP, GC",D - Sale to issuer,$28.63,-833,55996,-1%,"-$23,849",,,,,MYGN
169,,2019-10-01 18:39:21,2019-09-30,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$28.63,-5313,142095,-4%,"-$152,111",,,,,MYGN
170,,2019-10-01 18:37:06,2019-09-30,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$28.63,-725,79059,-1%,"-$20,757",,,,,MYGN
171,,2019-10-01 18:29:56,2019-09-30,MYGN,Ford Alexander,"Pres, MWH",D - Sale to issuer,$28.63,-8483,148404,-5%,"-$242,868",,,,,MYGN
172,,2019-10-01 18:27:43,2019-09-30,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$28.63,-10701,183440,-6%,"-$306,370",,,,,MYGN
173,,2019-10-01 18:20:21,2019-09-30,MYGN,Lambert Nicole,"Pres, MGL",D - Sale to issuer,$28.63,-1182,63504,-2%,"-$33,841",,,,,MYGN
174,,2019-10-01 18:20:20,2019-09-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$28.63,-27022,522216,-5%,"-$773,640",,,,,MYGN
175,,2019-09-26 17:15:59,2019-09-25,MYGN,Capone Mark Christopher,"Pres, C.E.O.",A - Grant,$0.00,142500,549238,+35%,+$0,,,,,MYGN
176,,2019-09-26 17:15:59,2019-09-25,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$29.93,-34095,549238,-6%,"-$1,020,463",,,,,MYGN
177,,2019-09-26 17:12:21,2019-09-25,MYGN,Tobin Bernard,Pres Crescendo BioScience,A - Grant,$0.00,35000,171743,+26%,+$0,,,,,MYGN
178,,2019-09-26 17:12:21,2019-09-25,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$29.93,-9297,171743,-5%,"-$278,259",,,,,MYGN
179,,2019-09-26 17:11:06,2019-09-25,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,30000,147408,+26%,+$0,,,,,MYGN
180,,2019-09-26 17:11:06,2019-09-25,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$29.93,-5609,147408,-4%,"-$167,877",,,,,MYGN
181,,2019-09-26 17:06:44,2019-09-25,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$29.93,-5794,79784,-7%,"-$173,414",,,,,MYGN
182,,2019-09-26 17:01:25,2019-09-25,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,27000,155550,+21%,+$0,,,,,MYGN
183,,2019-09-26 17:01:25,2019-09-25,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$29.93,-6321,155550,-4%,"-$189,188",,,,,MYGN
184,,2019-09-26 16:56:32,2019-09-25,MYGN,Jackson Benjamin,"E.VP, GC",A - Grant,$0.00,40000,56829,+238%,+$0,,,,,MYGN
185,,2019-09-26 16:56:32,2019-09-25,MYGN,Jackson Benjamin,"E.VP, GC",D - Sale to issuer,$29.93,-820,56829,-1%,"-$24,543",,,,,MYGN
186,,2019-09-26 16:54:52,2019-09-25,MYGN,Lambert Nicole,"Pres, MGL",A - Grant,$0.00,40000,64686,+162%,+$0,,,,,MYGN
187,,2019-09-26 16:54:52,2019-09-25,MYGN,Lambert Nicole,"Pres, MGL",D - Sale to issuer,$29.93,-1269,64686,-2%,"-$37,981",,,,,MYGN
188,,2019-09-26 16:48:19,2019-09-25,MYGN,Ford Alexander,"Pres, MWH",A - Grant,$0.00,47500,156887,+43%,+$0,,,,,MYGN
189,,2019-09-26 16:48:19,2019-09-25,MYGN,Ford Alexander,"Pres, MWH",D - Sale to issuer,$29.93,-11920,156887,-7%,"-$356,766",,,,,MYGN
190,,2019-09-26 16:43:31,2019-09-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,38000,194141,+24%,+$0,,,,,MYGN
191,,2019-09-26 16:43:31,2019-09-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$29.93,-9758,194141,-5%,"-$292,057",,,,,MYGN
192,,2019-09-26 16:12:15,2019-09-25,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,47500,156146,+44%,+$0,,,,,MYGN
193,,2019-09-26 16:12:15,2019-09-25,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$29.93,-11920,156146,-7%,"-$356,766",,,,,MYGN
194,D,2019-08-02 17:45:49,2019-08-01,MYGN,Capone Mark Christopher,"Pres, C.E.O.",M - OptEx,$26.38,137000,440833,+45%,"+$3,614,330",,,,,MYGN
195,D,2019-08-02 17:45:49,2019-08-01,MYGN,Capone Mark Christopher,"Pres, C.E.O.",S - Sale+OE,$44.00,-137000,440833,-24%,"-$6,028,000",,,,,MYGN
196,D,2019-08-02 16:44:19,2019-08-01,MYGN,King Gary A.,EVP International Ops,M - OptEx,$23.73,60000,134871,+80%,"+$1,423,900",,,,,MYGN
197,D,2019-08-02 16:44:19,2019-08-01,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$43.49,-60000,134871,-31%,"-$2,609,329",,,,,MYGN
198,,2019-08-02 16:40:42,2019-08-01,MYGN,Tobin Bernard,Pres Crescendo BioScience,S - Sale,$40.00,-11712,146040,-7%,"-$468,480",,,,,MYGN
199,,2019-08-02 16:32:48,2019-08-01,MYGN,Riggsbee Richard Bryan,CFO,S - Sale,$41.50,-25000,120566,-17%,"-$1,037,575",,,,,MYGN
200,,2019-03-12 17:56:10,2019-03-12,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",S - Sale,$31.00,-1975,122604,-2%,"-$61,225",,,,,MYGN
201,,2019-01-03 13:20:38,2019-01-02,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$29.00,-3734,157752,-2%,"-$108,286",,,,,MYGN
202,,2018-11-30 12:57:19,2018-11-29,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,9360,45103,+26%,+$0,,,,,MYGN
203,,2018-11-30 12:54:28,2018-11-29,MYGN,Langer Dennis,Dir,A - Grant,$0.00,9360,49103,+24%,+$0,,,,,MYGN
204,,2018-11-30 12:52:17,2018-11-29,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,9360,36603,+34%,+$0,,,,,MYGN
205,,2018-11-30 12:49:08,2018-11-29,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,9360,43103,+28%,+$0,,,,,MYGN
206,,2018-11-30 12:46:35,2018-11-29,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,9360,49103,+24%,+$0,,,,,MYGN
207,,2018-11-30 12:41:52,2018-11-29,MYGN,Henderson John T,Dir,A - Grant,$0.00,9360,59403,+19%,+$0,,,,,MYGN
208,,2018-10-19 11:46:09,2018-10-17,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$44.45,-3327,146966,-2%,"-$147,885",,,,,MYGN
209,,2018-10-02 09:18:43,2018-09-30,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$46.00,-5313,124265,-4%,"-$244,398",,,,,MYGN
210,,2018-10-02 09:16:10,2018-09-30,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$46.00,-725,85578,-1%,"-$33,350",,,,,MYGN
211,,2018-10-02 09:13:12,2018-09-30,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$46.00,-7153,133973,-5%,"-$329,038",,,,,MYGN
212,,2018-10-02 09:10:43,2018-09-30,MYGN,Sanders Walter Lloyd,Pres Myriad Oncology,D - Sale to issuer,$46.00,-1258,36195,-3%,"-$57,868",,,,,MYGN
213,,2018-10-02 09:05:07,2018-09-30,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$46.00,-11107,161486,-6%,"-$510,922",,,,,MYGN
214,,2018-10-02 09:02:13,2018-09-30,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$46.00,-8483,120524,-7%,"-$390,218",,,,,MYGN
215,,2018-10-02 08:58:12,2018-09-30,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$46.00,-10701,166049,-6%,"-$492,246",,,,,MYGN
216,,2018-10-02 08:53:34,2018-09-30,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$46.00,-10542,144174,-7%,"-$484,932",,,,,MYGN
217,,2018-10-02 08:49:31,2018-09-30,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$46.00,-11942,150293,-7%,"-$549,332",,,,,MYGN
218,,2018-10-02 08:45:28,2018-09-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$46.00,-27022,440833,-6%,"-$1,243,012",,,,,MYGN
219,,2018-09-26 14:55:15,2018-09-25,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$46.65,-18295,467855,-4%,"-$853,462",,,,,MYGN
220,,2018-09-26 14:50:41,2018-09-25,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$46.65,-6653,129007,-5%,"-$310,362",,,,,MYGN
221,,2018-09-26 14:43:42,2018-09-25,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$46.65,-5544,176750,-3%,"-$258,628",,,,,MYGN
222,,2018-09-26 14:40:27,2018-09-25,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$46.65,-5544,154716,-3%,"-$258,628",,,,,MYGN
223,,2018-09-26 14:36:27,2018-09-25,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$46.65,-6653,162235,-4%,"-$310,362",,,,,MYGN
224,,2018-09-26 14:33:57,2018-09-25,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$46.65,-2897,86303,-3%,"-$135,145",,,,,MYGN
225,,2018-09-26 14:30:16,2018-09-25,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$46.65,-3327,141126,-2%,"-$155,205",,,,,MYGN
226,,2018-09-26 14:27:05,2018-09-25,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$46.65,-4958,172593,-3%,"-$231,291",,,,,MYGN
227,,2018-09-26 14:23:52,2018-09-25,MYGN,Sanders Walter Lloyd,Pres Myriad Oncology,D - Sale to issuer,$46.65,-1664,37453,-4%,"-$77,626",,,,,MYGN
228,,2018-09-26 14:20:17,2018-09-25,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$46.65,-2952,129578,-2%,"-$137,711",,,,,MYGN
229,,2018-09-21 12:27:48,2018-09-19,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,27000,132530,+26%,+$0,,,,,MYGN
230,,2018-09-21 12:25:08,2018-09-19,MYGN,Tobin Bernard,Pres Crescendo BioScience,A - Grant,$0.00,35000,177551,+25%,+$0,,,,,MYGN
231,,2018-09-21 12:22:20,2018-09-19,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,27000,144453,+23%,+$0,,,,,MYGN
232,,2018-09-21 12:19:11,2018-09-19,MYGN,Verratti Mark,Pres Assurex Health Inc.,A - Grant,$0.00,40000,89200,+81%,+$0,,,,,MYGN
233,,2018-09-21 12:14:17,2018-09-19,MYGN,Ford Alexander,"Pres, MGL",A - Grant,$0.00,60000,135660,+79%,+$0,,,,,MYGN
234,,2018-09-21 12:11:46,2018-09-19,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,50000,182294,+38%,+$0,,,,,MYGN
235,,2018-09-21 12:08:32,2018-09-19,MYGN,Marsh Richard M,"E.VP, GC",A - Grant,$0.00,50000,160260,+45%,+$0,,,,,MYGN
236,,2018-09-21 12:06:06,2018-09-19,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,60000,168888,+55%,+$0,,,,,MYGN
237,,2018-09-21 12:02:38,2018-09-19,MYGN,Capone Mark Christopher,"Pres, C.E.O.",A - Grant,$0.00,165000,486150,+51%,+$0,,,,,MYGN
238,,2018-09-18 16:22:37,2018-09-17,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$46.35,-6515,132294,-5%,"-$301,970",,,,,MYGN
239,,2018-09-18 16:15:45,2018-09-17,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$46.35,-11025,321150,-3%,"-$511,009",,,,,MYGN
240,,2018-09-18 16:13:03,2018-09-17,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$46.35,-6314,110260,-5%,"-$292,654",,,,,MYGN
241,,2018-09-18 14:35:14,2018-09-17,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$46.35,-5101,117453,-4%,"-$236,431",,,,,MYGN
242,,2018-09-18 14:26:54,2018-09-17,MYGN,Sanders Walter Lloyd,Pres Myriad Oncology,D - Sale to issuer,$46.35,-844,24117,-3%,"-$39,119",,,,,MYGN
243,,2018-09-18 14:21:13,2018-09-17,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$46.35,-1830,75660,-2%,"-$84,821",,,,,MYGN
244,,2018-09-18 14:18:24,2018-09-17,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$46.35,-3148,105530,-3%,"-$145,910",,,,,MYGN
245,D,2018-06-19 16:49:47,2018-06-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$30.12,60000,138809,+76%,"+$1,807,200",,,,,MYGN
246,D,2018-06-19 16:49:47,2018-06-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$40.12,-60000,138809,-30%,"-$2,407,200",,,,,MYGN
247,D,2018-06-19 16:46:34,2018-06-18,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$30.34,33000,124197,+36%,"+$1,001,220",,,,,MYGN
248,D,2018-06-19 16:46:34,2018-06-18,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$40.00,-33000,124197,-21%,"-$1,320,000",,,,,MYGN
249,DM,2018-06-08 17:37:06,2018-06-06,MYGN,Langer Dennis,Dir,M - OptEx,$21.29,20369,39743,+105%,"+$433,656",,,,,MYGN
250,DM,2018-06-08 17:37:06,2018-06-06,MYGN,Langer Dennis,Dir,S - Sale+OE,$39.35,-20369,39743,-34%,"-$801,594",,,,,MYGN
251,DM,2018-06-07 16:00:50,2018-06-05,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$24.39,30000,27243,-1088%,"+$731,700",,,,,MYGN
252,DM,2018-06-07 16:00:50,2018-06-05,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$39.69,-30000,27243,-52%,"-$1,190,589",,,,,MYGN
253,DM,2018-06-05 17:45:13,2018-06-01,MYGN,Langer Dennis,Dir,M - OptEx,$23.79,49631,39743,-502%,"+$1,180,944",,,,,MYGN
254,DM,2018-06-05 17:45:13,2018-06-01,MYGN,Langer Dennis,Dir,S - Sale+OE,$39.30,-49631,39743,-56%,"-$1,950,277",,,,,MYGN
255,D,2018-06-01 17:43:57,2018-05-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",M - OptEx,$22.93,90000,332175,+37%,"+$2,063,700",,,,,MYGN
256,D,2018-06-01 17:43:57,2018-05-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",S - Sale+OE,$38.00,-90000,332175,-21%,"-$3,420,000",,,,,MYGN
257,D,2018-06-01 16:43:17,2018-05-30,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$30.34,33139,123769,+37%,"+$1,005,437",,,,,MYGN
258,D,2018-06-01 16:43:17,2018-05-30,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$38.00,-33139,123769,-21%,"-$1,259,282",,,,,MYGN
259,D,2018-06-01 16:37:30,2018-05-30,MYGN,Langer Dennis,Dir,M - OptEx,$24.39,10000,39743,+34%,"+$243,900",,,,,MYGN
260,D,2018-06-01 16:37:30,2018-05-30,MYGN,Langer Dennis,Dir,S - Sale+OE,$37.92,-10000,39743,-20%,"-$379,245",,,,,MYGN
261,D,2018-05-21 19:54:46,2018-05-21,MYGN,Langer Dennis,Dir,M - OptEx,$24.39,10000,39743,+34%,"+$243,900",,,,,MYGN
262,D,2018-05-21 19:54:46,2018-05-21,MYGN,Langer Dennis,Dir,S - Sale+OE,$35.90,-10000,39743,-20%,"-$359,000",,,,,MYGN
263,D,2018-01-22 18:16:15,2018-01-22,MYGN,King Gary A.,EVP International Ops,M - OptEx,$19.28,34445,121968,+39%,"+$664,110",,,,,MYGN
264,D,2018-01-22 18:16:15,2018-01-22,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$39.67,-34445,121968,-22%,"-$1,366,588",,,,,MYGN
265,D,2018-01-22 18:12:17,2018-01-22,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$29.79,41429,123769,+50%,"+$1,234,138",,,,,MYGN
266,D,2018-01-22 18:12:17,2018-01-22,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$40.25,-37654,123769,-23%,"-$1,515,611",,,,,MYGN
267,D,2018-01-19 14:26:16,2018-01-18,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$30.12,40000,119994,+50%,"+$1,204,800",,,,,MYGN
268,D,2018-01-19 14:26:16,2018-01-18,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$38.25,-40000,119994,-25%,"-$1,530,000",,,,,MYGN
269,D,2018-01-19 14:21:57,2018-01-18,MYGN,King Gary A.,EVP International Ops,M - OptEx,$14.88,3120,121968,+3%,"+$46,426",,,,,MYGN
270,D,2018-01-19 14:21:57,2018-01-18,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$38.12,-3120,121968,-2%,"-$118,934",,,,,MYGN
271,M,2018-01-16 15:18:31,2017-10-04,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-4500,119994,-4%,-$0,,,,,MYGN
272,,2018-01-16 15:18:31,2018-01-12,MYGN,Marsh Richard M,"E.VP, GC",S - Sale,$36.25,-13759,119994,-10%,"-$498,764",,,,,MYGN
273,,2018-01-03 19:39:15,2018-01-02,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$34.91,-3621,142551,-2%,"-$126,409",,,,,MYGN
274,,2017-12-15 15:09:39,2017-12-14,MYGN,Gilbert Walter Phd,Dir,S - Sale,$33.19,-7500,27243,-22%,"-$248,925",,,,,MYGN
275,,2017-12-12 12:16:28,2017-12-11,MYGN,Dreismann Heinrich,Dir,S - Sale,$33.50,-6000,33743,-15%,"-$201,000",,,,,MYGN
276,,2017-11-30 19:28:21,2017-11-30,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,7219,39743,+22%,+$0,,,,,MYGN
277,,2017-11-30 19:26:12,2017-11-30,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,7219,34743,+26%,+$0,,,,,MYGN
278,,2017-11-30 19:20:07,2017-11-30,MYGN,Henderson John T,Dir,A - Grant,$0.00,7219,50043,+17%,+$0,,,,,MYGN
279,,2017-11-30 19:17:51,2017-11-30,MYGN,Langer Dennis,Dir,A - Grant,$0.00,7219,39743,+22%,+$0,,,,,MYGN
280,,2017-11-30 19:14:33,2017-11-30,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,7219,39743,+22%,+$0,,,,,MYGN
281,,2017-11-30 19:11:41,2017-11-30,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,7219,35743,+25%,+$0,,,,,MYGN
282,,2017-11-14 17:02:16,2017-11-13,MYGN,Ford Alexander,"Pres, MGL",S - Sale,$31.64,-3031,76769,-4%,"-$95,897",,,,,MYGN
283,,2017-10-17 17:45:42,2017-10-17,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$35.84,-3522,109988,-3%,"-$126,228",,,,,MYGN
284,,2017-10-03 17:23:11,2017-09-30,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$36.18,-8980,79800,-10%,"-$324,896",,,,,MYGN
285,,2017-10-03 17:20:48,2017-09-30,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$36.18,-11690,146172,-7%,"-$422,944",,,,,MYGN
286,,2017-10-03 17:17:51,2017-09-30,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$36.18,-7572,121917,-6%,"-$273,955",,,,,MYGN
287,,2017-10-03 16:48:33,2017-09-30,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$36.18,-3693,108184,-3%,"-$133,613",,,,,MYGN
288,,2017-10-03 16:45:25,2017-09-30,MYGN,Verratti Mark,Pres Assurex Health Inc.,D - Sale to issuer,$36.18,-800,49200,-2%,"-$28,944",,,,,MYGN
289,,2017-10-03 16:43:53,2017-09-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$36.18,-28605,332175,-8%,"-$1,034,929",,,,,MYGN
290,,2017-10-03 16:40:06,2017-09-30,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$36.18,-12642,113510,-10%,"-$457,388",,,,,MYGN
291,,2017-10-03 16:34:46,2017-09-30,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$36.18,-11160,137885,-7%,"-$403,769",,,,,MYGN
292,,2017-10-03 16:31:53,2017-09-30,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$36.18,-11328,138809,-8%,"-$409,847",,,,,MYGN
293,,2017-09-19 17:50:20,2017-09-17,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$33.05,-5400,129489,-4%,"-$178,470",,,,,MYGN
294,,2017-09-19 17:48:05,2017-09-17,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$33.05,-1937,88780,-2%,"-$64,018",,,,,MYGN
295,,2017-09-19 17:45:43,2017-09-17,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$33.05,-2188,111877,-2%,"-$72,313",,,,,MYGN
296,,2017-09-19 17:28:03,2017-09-17,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$33.05,-6897,150137,-4%,"-$227,946",,,,,MYGN
297,,2017-09-19 17:24:43,2017-09-17,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$33.05,-6684,149045,-4%,"-$220,906",,,,,MYGN
298,,2017-09-19 17:20:00,2017-09-17,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$33.05,-11671,360780,-3%,"-$385,727",,,,,MYGN
299,,2017-09-15 17:05:07,2017-09-13,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,30000,134889,+29%,+$0,,,,,MYGN
300,,2017-09-15 16:58:15,2017-09-13,MYGN,Verratti Mark,Pres Assurex Health Inc.,A - Grant,$0.00,40000,50000,+400%,+$0,,,,,MYGN
301,,2017-09-15 16:52:43,2017-09-13,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,50000,157034,+47%,+$0,,,,,MYGN
302,,2017-09-15 16:46:10,2017-09-13,MYGN,Tobin Bernard,Pres Crescendo BioScience,A - Grant,$0.00,40000,157862,+34%,+$0,,,,,MYGN
303,,2017-09-15 16:44:37,2017-09-13,MYGN,Ford Alexander,"Pres, MGL",A - Grant,$0.00,60000,90717,+195%,+$0,,,,,MYGN
304,,2017-09-15 16:41:50,2017-09-13,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,30000,114065,+36%,+$0,,,,,MYGN
305,,2017-09-15 16:39:38,2017-09-13,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,60000,126152,+91%,+$0,,,,,MYGN
306,,2017-09-15 16:32:53,2017-09-13,MYGN,Marsh Richard M,"E.VP, GC",A - Grant,$0.00,50000,155729,+47%,+$0,,,,,MYGN
307,,2017-09-15 16:31:54,2017-09-13,MYGN,Capone Mark Christopher,"Pres, C.E.O.",A - Grant,$0.00,165000,372451,+80%,+$0,,,,,MYGN
308,D,2017-09-05 14:08:36,2017-09-01,MYGN,Henderson John T,Dir,M - OptEx,$16.46,30000,42824,+234%,"+$493,800",,,,,MYGN
309,D,2017-09-05 14:08:36,2017-09-01,MYGN,Henderson John T,Dir,S - Sale+OE,$30.30,-30000,42824,-41%,"-$909,040",,,,,MYGN
310,M,2017-02-23 11:20:18,2017-02-22,MYGN,Henderson John T,Dir,P - Purchase,$18.66,6000,42824,+16%,"+$111,930",1.0,3.0,2.0,,MYGN
311,,2017-01-04 13:22:29,2017-01-03,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$16.93,-2631,116360,-2%,"-$44,543",4.0,3.0,-6.0,,MYGN
312,,2016-12-01 19:26:10,2016-12-01,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,15024,28524,+111%,+$0,0.0,1.0,0.0,,MYGN
313,,2016-12-01 19:21:00,2016-12-01,MYGN,Langer Dennis,Dir,A - Grant,$0.00,15024,32524,+86%,+$0,0.0,1.0,0.0,,MYGN
314,,2016-12-01 19:16:28,2016-12-01,MYGN,Henderson John T,Dir,A - Grant,$0.00,15024,36824,+69%,+$0,0.0,1.0,0.0,,MYGN
315,,2016-12-01 19:13:47,2016-12-01,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,15024,27524,+120%,+$0,0.0,1.0,0.0,,MYGN
316,,2016-12-01 19:10:59,2016-12-01,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,15024,32524,+86%,+$0,0.0,1.0,0.0,,MYGN
317,,2016-12-01 19:06:33,2016-12-01,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,15024,32524,+86%,+$0,0.0,1.0,0.0,,MYGN
318,,2016-10-17 19:09:47,2016-10-17,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$19.31,-3522,66152,-5%,"-$68,010",3.0,2.0,-8.0,-7.0,MYGN
319,,2016-10-03 18:08:39,2016-09-30,MYGN,Tobin Bernard,Pres Crescendo BioScience,D - Sale to issuer,$20.58,-4661,118991,-4%,"-$95,923",1.0,4.0,-4.0,-7.0,MYGN
320,,2016-10-03 17:55:54,2016-09-30,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$20.58,-1937,29213,-6%,"-$39,863",1.0,4.0,-4.0,-7.0,MYGN
321,,2016-10-03 17:54:00,2016-09-30,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$20.58,-5459,107034,-5%,"-$112,346",1.0,4.0,-4.0,-7.0,MYGN
322,,2016-10-03 17:53:07,2016-09-30,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$20.58,-1641,82891,-2%,"-$33,772",1.0,4.0,-4.0,-7.0,MYGN
323,,2016-10-03 17:51:16,2016-09-30,MYGN,Riggsbee Richard Bryan,CFO,D - Sale to issuer,$20.58,-5599,69674,-7%,"-$115,227",1.0,4.0,-4.0,-7.0,MYGN
324,,2016-10-03 17:50:14,2016-09-30,MYGN,Wenstrup Richard,Chief Medical Officer,D - Sale to issuer,$20.58,-931,50207,-2%,"-$19,160",1.0,4.0,-4.0,-7.0,MYGN
325,,2016-10-03 17:48:34,2016-09-30,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$20.58,-3646,110134,-3%,"-$75,035",1.0,4.0,-4.0,-7.0,MYGN
326,,2016-10-03 17:46:49,2016-09-30,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$20.58,-4050,103449,-4%,"-$83,349",1.0,4.0,-4.0,-7.0,MYGN
327,,2016-10-03 17:45:18,2016-09-30,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$20.58,-9238,207451,-4%,"-$190,118",1.0,4.0,-4.0,-7.0,MYGN
328,,2016-09-20 09:08:11,2016-09-17,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",D - Sale to issuer,$20.92,-2188,84532,-3%,"-$45,773",-1.0,3.0,-5.0,-9.0,MYGN
329,,2016-09-20 09:03:32,2016-09-17,MYGN,Wenstrup Richard,Chief Medical Officer,D - Sale to issuer,$20.92,-931,51138,-2%,"-$19,477",-1.0,3.0,-5.0,-9.0,MYGN
330,,2016-09-20 08:56:38,2016-09-17,MYGN,King Gary A.,EVP International Ops,D - Sale to issuer,$20.92,-3721,107499,-3%,"-$77,843",-1.0,3.0,-5.0,-9.0,MYGN
331,,2016-09-20 08:52:10,2016-09-17,MYGN,Ford Alexander,"Pres, MGL",D - Sale to issuer,$20.92,-1335,31150,-4%,"-$27,928",-1.0,3.0,-5.0,-9.0,MYGN
332,,2016-09-20 08:43:15,2016-09-17,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$20.92,-4752,112493,-4%,"-$99,412",-1.0,3.0,-5.0,-9.0,MYGN
333,,2016-09-20 08:31:22,2016-09-17,MYGN,Marsh Richard M,"E.VP, GC",D - Sale to issuer,$20.92,-4606,113780,-4%,"-$96,358",-1.0,3.0,-5.0,-9.0,MYGN
334,,2016-09-20 08:16:31,2016-09-17,MYGN,Capone Mark Christopher,"Pres, C.E.O.",D - Sale to issuer,$20.92,-8042,216689,-4%,"-$168,239",-1.0,3.0,-5.0,-9.0,MYGN
335,,2016-09-16 14:29:11,2016-09-14,MYGN,Drosos Virginia,Pres Assurex Health,A - Grant,$0.00,50000,50000,New,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
336,,2016-09-16 14:24:56,2016-09-14,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,30000,86720,+53%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
337,,2016-09-16 14:04:43,2016-09-14,MYGN,Wenstrup Richard,Chief Medical Officer,A - Grant,$0.00,30000,52069,+136%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
338,,2016-09-16 14:03:35,2016-09-14,MYGN,Tobin Bernard,Pres Crescendo BioScience,A - Grant,$0.00,89608,126220,+245%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
339,,2016-09-16 14:00:36,2016-09-14,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,30000,111220,+37%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
340,,2016-09-16 13:59:12,2016-09-14,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,46508,117245,+66%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
341,,2016-09-16 13:55:16,2016-09-14,MYGN,Marsh Richard M,"E.VP, GC",A - Grant,$0.00,45077,118386,+61%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
342,,2016-09-16 13:46:37,2016-09-14,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,47700,75273,+173%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
343,,2016-09-16 13:30:55,2016-09-14,MYGN,Capone Mark Christopher,"Pres, C.E.O.",A - Grant,$0.00,78705,224731,+54%,+$0,-6.0,-4.0,-16.0,-15.0,MYGN
344,DM,2016-09-13 10:38:54,2016-09-09,MYGN,Henderson John T,Dir,M - OptEx,$10.60,30000,21800,-366%,"+$318,000",0.0,0.0,-9.0,-8.0,MYGN
345,DM,2016-09-13 10:38:54,2016-09-09,MYGN,Henderson John T,Dir,S - Sale+OE,$20.49,-30000,21800,-58%,"-$614,816",0.0,0.0,-9.0,-8.0,MYGN
346,,2016-08-19 11:41:17,2016-08-19,MYGN,Capone Mark Christopher,"Pres, C.E.O.",P - Purchase,$21.24,10000,146026,+7%,"+$212,400",0.0,-3.0,-2.0,-12.0,MYGN
347,,2016-08-15 11:31:10,2016-08-12,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",P - Purchase,$21.49,1000,56720,+2%,"+$21,490",-1.0,-1.0,-3.0,-21.0,MYGN
348,D,2016-06-22 17:05:30,2016-06-21,MYGN,Ford Alexander,"Pres, MGL",M - OptEx,$18.49,16449,32485,+103%,"+$304,092",-1.0,-5.0,4.0,-42.0,MYGN
349,D,2016-06-22 17:05:30,2016-06-21,MYGN,Ford Alexander,"Pres, MGL",S - Sale+OE,$30.87,-18637,32485,-36%,"-$575,385",-1.0,-5.0,4.0,-42.0,MYGN
350,D,2016-06-16 17:10:07,2016-06-16,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$23.98,4170,73309,+6%,"+$99,997",-2.0,1.0,2.0,-42.0,MYGN
351,D,2016-04-08 18:27:09,2016-04-06,MYGN,King Gary A.,EVP International Ops,M - OptEx,$18.00,15000,80640,+23%,"+$270,000",0.0,1.0,-11.0,-44.0,MYGN
352,D,2016-04-08 18:27:09,2016-04-06,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$39.03,-15000,80640,-16%,"-$585,450",0.0,1.0,-11.0,-44.0,MYGN
353,D,2016-04-05 10:24:01,2016-04-01,MYGN,King Gary A.,EVP International Ops,M - OptEx,$14.88,15000,80640,+23%,"+$223,200",-1.0,1.0,-5.0,-46.0,MYGN
354,D,2016-04-05 10:24:01,2016-04-01,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$38.12,-15000,80640,-16%,"-$571,800",-1.0,1.0,-5.0,-46.0,MYGN
355,,2015-12-14 15:46:22,2015-12-11,MYGN,Gilbert Walter Phd,Dir,S - Sale,$42.23,-5000,12500,-29%,"-$211,150",1.0,2.0,0.0,-28.0,MYGN
356,,2015-12-09 17:34:55,2015-12-08,MYGN,Phanstiel S. Louise,Dir,S - Sale,$44.00,-5000,13500,-27%,"-$220,002",0.0,2.0,-1.0,-20.0,MYGN
357,,2015-12-07 18:05:19,2015-12-03,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,7500,18500,+68%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
358,,2015-12-07 18:05:19,2015-12-04,MYGN,Phanstiel S. Louise,Dir,G - Gift,$0.00,10000,18500,+118%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
359,,2015-12-07 16:57:16,2015-12-03,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,7500,17500,+75%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
360,,2015-12-07 16:53:35,2015-12-03,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,7500,17500,+75%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
361,,2015-12-07 16:49:42,2015-12-03,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,7500,17500,+75%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
362,,2015-12-07 16:45:30,2015-12-03,MYGN,Langer Dennis,Dir,A - Grant,$0.00,7500,17500,+75%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
363,,2015-12-07 16:38:00,2015-12-03,MYGN,Henderson John T,Dir,A - Grant,$0.00,7500,21800,+52%,+$0,3.0,-1.0,-1.0,-19.0,MYGN
364,D,2015-11-05 18:14:19,2015-11-05,MYGN,Dreismann Heinrich,Dir,M - OptEx,$26.50,60000,10000,-120%,"+$1,590,000",-1.0,-1.0,-3.0,-22.0,MYGN
365,D,2015-11-05 18:14:19,2015-11-05,MYGN,Dreismann Heinrich,Dir,S - Sale+OE,$44.44,-60000,10000,-86%,"-$2,666,118",-1.0,-1.0,-3.0,-22.0,MYGN
366,DM,2015-11-05 16:26:45,2015-10-21,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-4367,68384,-6%,-$0,-1.0,-1.0,-3.0,-22.0,MYGN
367,D,2015-11-05 16:26:45,2015-11-04,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$22.93,35000,68384,+105%,"+$802,550",-1.0,-1.0,-3.0,-22.0,MYGN
368,D,2015-11-05 16:26:45,2015-11-04,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$44.50,-35000,68384,-34%,"-$1,557,500",-1.0,-1.0,-3.0,-22.0,MYGN
369,D,2015-10-28 18:34:21,2015-10-28,MYGN,King Gary A.,EVP International Ops,M - OptEx,$23.98,10000,80573,+14%,"+$239,800",-4.0,-1.0,2.0,-14.0,MYGN
370,D,2015-10-28 18:34:21,2015-10-28,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$42.82,-10000,80573,-11%,"-$428,200",-4.0,-1.0,2.0,-14.0,MYGN
371,D,2015-10-28 16:16:31,2015-10-28,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$22.93,50962,70737,+258%,"+$1,168,559",-4.0,-1.0,2.0,-14.0,MYGN
372,D,2015-10-28 16:16:31,2015-10-28,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$41.86,-50962,70737,-42%,"-$2,133,269",-4.0,-1.0,2.0,-14.0,MYGN
373,DM,2015-10-27 17:01:59,2015-10-23,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$17.83,24767,70737,+54%,"+$441,642",3.0,0.0,6.0,-10.0,MYGN
374,DM,2015-10-27 17:01:59,2015-10-23,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$41.80,-24767,70737,-26%,"-$1,035,261",3.0,0.0,6.0,-10.0,MYGN
375,,2015-10-19 12:44:40,2015-10-17,MYGN,Riggsbee Richard Bryan,CFO,F - Tax,$39.31,-2427,27573,-8%,"-$95,405",2.0,6.0,8.0,-8.0,MYGN
376,D,2015-10-07 16:56:59,2015-09-02,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-1000,72751,-1%,-$0,-2.0,-6.0,15.0,-2.0,MYGN
377,D,2015-10-07 16:56:59,2015-10-06,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$30.25,6208,72751,+9%,"+$187,821",-2.0,-6.0,15.0,-2.0,MYGN
378,,2015-09-22 18:58:26,2015-09-15,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,24000,55157,+77%,+$0,1.0,-6.0,4.0,-6.0,MYGN
379,,2015-09-22 18:58:26,2015-09-17,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",F - Tax,$41.39,-2188,55157,-4%,"-$90,561",1.0,-6.0,4.0,-6.0,MYGN
380,,2015-09-17 18:47:12,2015-09-15,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,34500,80573,+75%,+$0,-4.0,-4.0,-6.0,-10.0,MYGN
381,,2015-09-17 18:47:12,2015-09-17,MYGN,King Gary A.,EVP International Ops,F - Tax,$41.39,-5400,80573,-6%,"-$223,506",-4.0,-4.0,-6.0,-10.0,MYGN
382,,2015-09-17 18:41:41,2015-09-15,MYGN,Wenstrup Richard,Chief Medical Officer,A - Grant,$0.00,11500,22069,+109%,+$0,-4.0,-4.0,-6.0,-10.0,MYGN
383,,2015-09-17 18:41:41,2015-09-17,MYGN,Wenstrup Richard,Chief Medical Officer,F - Tax,$41.39,-931,22069,-4%,"-$38,534",-4.0,-4.0,-6.0,-10.0,MYGN
384,D,2015-09-17 18:40:55,2015-09-17,MYGN,Lanchbury Jerry S,Chief Scientific Officer,F - Tax,$41.39,-6897,70737,-9%,"-$285,467",-4.0,-4.0,-6.0,-10.0,MYGN
385,DM,2015-09-17 18:40:55,2015-09-15,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$16.78,60270,70737,+576%,"+$1,011,563",-4.0,-4.0,-6.0,-10.0,MYGN
386,DM,2015-09-17 18:40:55,2015-09-15,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$39.89,-60270,70737,-46%,"-$2,403,921",-4.0,-4.0,-6.0,-10.0,MYGN
387,D,2015-09-17 18:32:26,2015-09-17,MYGN,Marsh Richard M,"E.VP, GC",F - Tax,$41.39,-6684,67543,-9%,"-$276,651",-4.0,-4.0,-6.0,-10.0,MYGN
388,D,2015-09-17 18:32:26,2015-09-16,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$22.93,35000,67543,+108%,"+$802,550",-4.0,-4.0,-6.0,-10.0,MYGN
389,D,2015-09-17 18:32:26,2015-09-16,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$41.25,-35000,67543,-34%,"-$1,443,750",-4.0,-4.0,-6.0,-10.0,MYGN
390,,2015-09-17 18:27:14,2015-09-17,MYGN,Capone Mark Christopher,"Pres, C.E.O.",F - Tax,$41.39,-11671,136026,-8%,"-$483,063",-4.0,-4.0,-6.0,-10.0,MYGN
391,,2015-09-17 18:26:30,2015-09-15,MYGN,Ford Alexander,"Pres, MGL",A - Grant,$0.00,16500,34094,+94%,+$0,-4.0,-4.0,-6.0,-10.0,MYGN
392,,2015-09-17 18:26:30,2015-09-17,MYGN,Ford Alexander,"Pres, MGL",F - Tax,$41.39,-1937,34094,-5%,"-$80,172",-4.0,-4.0,-6.0,-10.0,MYGN
393,D,2015-09-16 16:34:44,2015-09-14,MYGN,King Gary A.,EVP International Ops,M - OptEx,$19.47,14562,51473,+39%,"+$283,522",0.0,-5.0,-7.0,-12.0,MYGN
394,D,2015-09-16 16:34:44,2015-09-14,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$39.41,-14562,51473,-22%,"-$573,888",0.0,-5.0,-7.0,-12.0,MYGN
395,D,2015-09-08 16:08:52,2015-09-03,MYGN,King Gary A.,EVP International Ops,M - OptEx,$19.47,25438,51473,+98%,"+$495,278",-1.0,1.0,1.0,-3.0,MYGN
396,D,2015-09-08 16:08:52,2015-09-03,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$39.41,-25438,51473,-33%,"-$1,002,512",-1.0,1.0,1.0,-3.0,MYGN
397,D,2015-09-02 16:24:43,2015-09-02,MYGN,King Gary A.,EVP International Ops,M - OptEx,$18.00,15000,51473,+41%,"+$270,000",-2.0,-1.0,-4.0,-7.0,MYGN
398,D,2015-09-02 16:24:43,2015-09-02,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$38.23,-15000,51473,-23%,"-$573,450",-2.0,-1.0,-4.0,-7.0,MYGN
399,D,2015-08-31 16:14:37,2015-08-28,MYGN,King Gary A.,EVP International Ops,M - OptEx,$14.88,30000,51473,+140%,"+$446,400",-2.0,2.0,-2.0,-6.0,MYGN
400,D,2015-08-31 16:14:37,2015-08-28,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$35.73,-30000,51473,-37%,"-$1,071,900",-2.0,2.0,-2.0,-6.0,MYGN
401,,2015-08-14 16:44:43,2015-08-13,MYGN,Lanchbury Jerry S,Chief Scientific Officer,A - Grant,$0.00,58754,77634,+311%,+$0,4.0,-1.0,19.0,4.0,MYGN
402,,2015-08-14 16:41:58,2015-08-13,MYGN,Marsh Richard M,"E.VP, GC",A - Grant,$0.00,56946,74227,+330%,+$0,4.0,-1.0,19.0,4.0,MYGN
403,,2015-08-14 16:38:33,2015-08-13,MYGN,Capone Mark Christopher,"Pres, C.E.O.",A - Grant,$0.00,99429,147697,+206%,+$0,4.0,-1.0,19.0,4.0,MYGN
404,D,2015-05-08 16:17:35,2014-11-03,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-6000,10424,-37%,-$0,3.0,2.0,-1.0,39.0,MYGN
405,D,2015-05-08 16:17:35,2015-05-06,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$18.00,5555,10424,+114%,"+$99,990",3.0,2.0,-1.0,39.0,MYGN
406,D,2015-03-03 17:24:30,2014-12-22,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-5324,16778,-24%,-$0,1.0,3.0,4.0,7.0,MYGN
407,D,2015-03-03 17:24:30,2015-03-02,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$18.00,5555,16778,+49%,"+$99,990",1.0,3.0,4.0,7.0,MYGN
408,,2015-01-06 14:12:18,2015-01-02,MYGN,Tobin Bernard,Pres Crescendo BioScience,A - Grant,$0.00,40000,35280,-847%,+$0,0.0,14.0,1.0,2.0,MYGN
409,,2015-01-06 14:12:18,2015-01-02,MYGN,Tobin Bernard,Pres Crescendo BioScience,F - Tax,$34.61,-4720,35280,-12%,"-$163,359",0.0,14.0,1.0,2.0,MYGN
410,,2014-12-04 17:29:06,2014-12-04,MYGN,Phanstiel S. Louise,Dir,A - Grant,$0.00,10000,11000,>999%,+$0,1.0,1.0,-2.0,-4.0,MYGN
411,,2014-12-04 17:27:56,2014-12-04,MYGN,Best Lawrence C,Dir,A - Grant,$0.00,10000,10000,New,+$0,1.0,1.0,-2.0,-4.0,MYGN
412,,2014-12-04 17:25:35,2014-12-04,MYGN,Langer Dennis,Dir,A - Grant,$0.00,10000,10000,New,+$0,1.0,1.0,-2.0,-4.0,MYGN
413,,2014-12-04 17:24:03,2014-12-04,MYGN,Dreismann Heinrich,Dir,A - Grant,$0.00,10000,10000,New,+$0,1.0,1.0,-2.0,-4.0,MYGN
414,,2014-12-04 17:22:11,2014-12-04,MYGN,Gilbert Walter Phd,Dir,A - Grant,$0.00,10000,10000,New,+$0,1.0,1.0,-2.0,-4.0,MYGN
415,,2014-12-04 17:20:46,2014-12-04,MYGN,Henderson John T,Dir,A - Grant,$0.00,10000,14300,+233%,+$0,1.0,1.0,-2.0,-4.0,MYGN
416,D,2014-11-06 11:47:23,2014-11-05,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$23.11,4329,18880,+30%,"+$100,037",0.0,-5.0,1.0,-4.0,MYGN
417,D,2014-11-06 11:35:33,2014-11-05,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$23.11,4329,10869,+66%,"+$100,037",0.0,-5.0,1.0,-4.0,MYGN
418,D,2014-11-05 16:08:13,2014-11-03,MYGN,King Gary A.,EVP International Ops,M - OptEx,$19.47,6568,50698,+15%,"+$127,879",1.0,-6.0,0.0,-5.0,MYGN
419,D,2014-11-05 16:08:13,2014-11-03,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$39.95,-6568,50698,-11%,"-$262,392",1.0,-6.0,0.0,-5.0,MYGN
420,,2014-10-20 13:26:57,2014-10-17,MYGN,Riggsbee Richard Bryan,CFO,A - Grant,$0.00,30000,30000,New,+$0,0.0,6.0,-7.0,-4.0,MYGN
421,D,2014-10-02 16:05:55,2014-09-30,MYGN,Evans James S,CFO,M - OptEx,$8.72,21850,48128,+83%,"+$190,606",-2.0,0.0,0.0,-8.0,MYGN
422,D,2014-10-02 16:05:55,2014-09-30,MYGN,Evans James S,CFO,S - Sale+OE,$38.99,-21850,48128,-31%,"-$851,886",-2.0,0.0,0.0,-8.0,MYGN
423,D,2014-09-26 16:18:01,2014-09-24,MYGN,Evans James S,CFO,M - OptEx,$30.12,8790,48128,+22%,"+$264,755",3.0,1.0,-2.0,-6.0,MYGN
424,D,2014-09-26 16:18:01,2014-09-24,MYGN,Evans James S,CFO,S - Sale+OE,$37.98,-8790,48128,-15%,"-$333,844",3.0,1.0,-2.0,-6.0,MYGN
425,DM,2014-09-23 17:58:29,2014-09-19,MYGN,Evans James S,CFO,M - OptEx,$25.41,110463,48128,-177%,"+$2,806,765",1.0,3.0,-3.0,-1.0,MYGN
426,DM,2014-09-23 17:58:29,2014-09-19,MYGN,Evans James S,CFO,S - Sale+OE,$37.89,-110463,48128,-70%,"-$4,185,642",1.0,3.0,-3.0,-1.0,MYGN
427,,2014-09-18 16:10:07,2014-09-17,MYGN,King Gary A.,EVP International Ops,A - Grant,$0.00,46000,50698,+979%,+$0,-1.0,2.0,0.0,-1.0,MYGN
428,,2014-09-18 16:08:53,2014-09-17,MYGN,McDade Ralph L,"Pres Myriad RBM, Inc.",A - Grant,$0.00,32000,32801,>999%,+$0,-1.0,2.0,0.0,-1.0,MYGN
429,,2014-09-18 16:07:44,2014-09-17,MYGN,Harrison Robert Gardner,CIO,A - Grant,$0.00,25000,25844,>999%,+$0,-1.0,2.0,0.0,-1.0,MYGN
430,,2014-09-18 16:06:32,2014-09-17,MYGN,Hart Jayne B.,EVP HR,A - Grant,$0.00,25000,26193,>999%,+$0,-1.0,2.0,0.0,-1.0,MYGN
431,,2014-09-18 16:05:18,2014-09-17,MYGN,Rogers Ronald S.,EVP Corp Communications,A - Grant,$0.00,16000,16000,New,+$0,-1.0,2.0,0.0,-1.0,MYGN
432,D,2014-07-15 07:59:49,2014-04-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-8544,6540,-57%,-$0,-3.0,-6.0,-3.0,-4.0,MYGN
433,D,2014-07-15 07:59:49,2014-07-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$9.04,24000,6540,-137%,"+$216,960",-3.0,-6.0,-3.0,-4.0,MYGN
434,D,2014-07-15 07:59:49,2014-07-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$39.50,-24000,6540,-79%,"-$948,000",-3.0,-6.0,-3.0,-4.0,MYGN
435,D,2014-07-15 07:57:37,2014-07-14,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$18.06,20000,14551,-367%,"+$361,200",-3.0,-6.0,-3.0,-4.0,MYGN
436,D,2014-07-15 07:57:37,2014-07-14,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$39.85,-20000,14551,-58%,"-$797,082",-3.0,-6.0,-3.0,-4.0,MYGN
437,D,2014-06-06 11:50:29,2014-06-05,MYGN,Henderson John T,Dir,M - OptEx,$7.60,5000,4300,-714%,"+$38,000",0.0,-4.0,7.0,-2.0,MYGN
438,D,2014-06-06 11:50:29,2014-06-05,MYGN,Henderson John T,Dir,S - Sale+OE,$35.70,-5000,4300,-54%,"-$178,511",0.0,-4.0,7.0,-2.0,MYGN
439,D,2014-05-09 17:57:25,2014-05-09,MYGN,Rogers Ronald S.,EVP Corp Communications,M - OptEx,$25.12,12500,0,-100%,"+$314,000",0.0,6.0,-4.0,-4.0,MYGN
440,D,2014-05-09 17:57:25,2014-05-09,MYGN,Rogers Ronald S.,EVP Corp Communications,S - Sale+OE,$36.01,-12500,0,-100%,"-$450,125",0.0,6.0,-4.0,-4.0,MYGN
441,D,2014-05-01 16:07:55,2014-04-30,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$13.28,30000,18285,-256%,"+$398,400",0.0,-7.0,-16.0,-5.0,MYGN
442,D,2014-05-01 16:07:55,2014-04-30,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$41.80,-30000,18285,-62%,"-$1,254,000",0.0,-7.0,-16.0,-5.0,MYGN
443,D,2014-04-25 17:27:46,2014-04-23,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$18.06,31516,18285,-238%,"+$569,179",1.0,3.0,-14.0,-3.0,MYGN
444,D,2014-04-25 17:27:46,2014-04-23,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$39.80,-31516,18285,-63%,"-$1,254,337",1.0,3.0,-14.0,-3.0,MYGN
445,D,2014-04-17 17:01:09,2014-04-02,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-3208,18285,-15%,-$0,0.0,6.0,-2.0,1.0,MYGN
446,D,2014-04-17 17:01:09,2014-04-16,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$18.06,28484,18285,-279%,"+$514,421",0.0,6.0,-2.0,1.0,MYGN
447,D,2014-04-17 17:01:09,2014-04-16,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$39.80,-28484,18285,-61%,"-$1,133,663",0.0,6.0,-2.0,1.0,MYGN
448,D,2014-04-07 16:44:41,2014-04-07,MYGN,Hart Jayne B.,EVP HR,M - OptEx,$23.41,79000,930,-101%,"+$1,849,515",-1.0,-7.0,0.0,-9.0,MYGN
449,D,2014-04-07 16:44:41,2014-04-07,MYGN,Hart Jayne B.,EVP HR,S - Sale+OE,$40.90,-79000,930,-99%,"-$3,230,863",-1.0,-7.0,0.0,-9.0,MYGN
450,D,2014-04-04 16:18:52,2014-04-02,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$14.87,90000,14551,-119%,"+$1,338,600",0.0,-8.0,0.0,-7.0,MYGN
451,D,2014-04-04 16:18:52,2014-04-02,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$39.70,-93000,14551,-86%,"-$3,691,783",0.0,-8.0,0.0,-7.0,MYGN
452,D,2014-04-04 16:16:58,2014-04-02,MYGN,Evans James S,CFO,M - OptEx,$30.34,80000,47609,-247%,"+$2,427,200",0.0,-8.0,0.0,-7.0,MYGN
453,D,2014-04-04 16:16:58,2014-04-02,MYGN,Evans James S,CFO,S - Sale+OE,$40.00,-80000,47609,-63%,"-$3,200,000",0.0,-8.0,0.0,-7.0,MYGN
454,D,2014-04-04 16:14:29,2014-02-24,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-11000,15084,-42%,-$0,0.0,-8.0,0.0,-7.0,MYGN
455,D,2014-04-04 16:14:29,2014-04-02,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$30.12,55000,15084,-138%,"+$1,656,600",0.0,-8.0,0.0,-7.0,MYGN
456,D,2014-04-04 16:14:29,2014-04-02,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$39.57,-55000,15084,-78%,"-$2,176,350",0.0,-8.0,0.0,-7.0,MYGN
457,D,2014-03-31 17:47:01,2014-03-31,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$23.11,4328,21493,+25%,"+$100,020",3.0,21.0,20.0,11.0,MYGN
458,D,2014-03-20 16:12:02,2014-03-19,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$30.12,55000,26084,-190%,"+$1,656,600",-5.0,-11.0,4.0,4.0,MYGN
459,D,2014-03-20 16:12:02,2014-03-19,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$37.00,-55000,26084,-68%,"-$2,035,000",-5.0,-11.0,4.0,4.0,MYGN
460,D,2014-03-19 10:02:56,2014-02-12,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-29572,26084,-53%,-$0,0.0,-5.0,6.0,5.0,MYGN
461,D,2014-03-19 10:02:56,2014-03-17,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$30.12,55000,26084,-190%,"+$1,656,600",0.0,-5.0,6.0,5.0,MYGN
462,D,2014-03-19 10:02:56,2014-03-17,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$35.15,-55000,26084,-68%,"-$1,933,305",0.0,-5.0,6.0,5.0,MYGN
463,D,2014-03-13 17:17:44,2014-03-12,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$9.04,50000,17165,-152%,"+$452,000",0.0,3.0,9.0,5.0,MYGN
464,D,2014-03-13 17:17:44,2014-03-12,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$34.37,-50000,17165,-74%,"-$1,718,290",0.0,3.0,9.0,5.0,MYGN
465,D,2014-03-11 17:05:53,2014-03-07,MYGN,Henderson John T,Dir,M - OptEx,$7.60,20000,4300,-127%,"+$152,000",2.0,1.0,15.0,6.0,MYGN
466,D,2014-03-11 17:05:53,2014-03-07,MYGN,Henderson John T,Dir,S - Sale+OE,$37.86,-20000,4300,-82%,"-$757,196",2.0,1.0,15.0,6.0,MYGN
467,D,2014-03-07 17:01:22,2014-03-05,MYGN,Henderson John T,Dir,M - OptEx,$7.60,5000,4300,-714%,"+$38,000",-1.0,-9.0,8.0,-6.0,MYGN
468,D,2014-03-07 17:01:22,2014-03-05,MYGN,Henderson John T,Dir,S - Sale+OE,$37.59,-5000,4300,-54%,"-$187,935",-1.0,-9.0,8.0,-6.0,MYGN
469,D,2014-02-26 18:18:15,2014-02-26,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$24.40,30000,0,-100%,"+$732,000",-2.0,0.0,-13.0,-3.0,MYGN
470,D,2014-02-26 18:18:15,2014-02-26,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$37.58,-30000,0,-100%,"-$1,127,319",-2.0,0.0,-13.0,-3.0,MYGN
471,D,2014-02-25 18:13:20,2014-02-25,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$18.99,95250,48268,-203%,"+$1,808,580",-1.0,-2.0,-9.0,-3.0,MYGN
472,D,2014-02-25 18:13:20,2014-02-25,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$37.83,-95250,48268,-66%,"-$3,603,308",-1.0,-2.0,-9.0,-3.0,MYGN
473,D,2014-02-24 17:59:04,2014-02-24,MYGN,King Gary A.,EVP International Ops,M - OptEx,$18.00,20000,2949,-117%,"+$360,000",-1.0,-5.0,-12.0,-2.0,MYGN
474,D,2014-02-24 17:59:04,2014-02-24,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$38.00,-20000,2949,-87%,"-$760,000",-1.0,-5.0,-12.0,-2.0,MYGN
475,D,2014-02-20 17:46:00,2014-02-20,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$13.25,17554,324,-102%,"+$232,677",3.0,3.0,1.0,3.0,MYGN
476,D,2014-02-20 17:46:00,2014-02-20,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$36.22,-17554,324,-98%,"-$635,753",3.0,3.0,1.0,3.0,MYGN
477,D,2014-02-20 17:38:53,2014-02-20,MYGN,Evans James S,CFO,M - OptEx,$7.27,30000,47609,+170%,"+$218,100",3.0,3.0,1.0,3.0,MYGN
478,D,2014-02-20 17:38:53,2014-02-20,MYGN,Evans James S,CFO,S - Sale+OE,$36.01,-30000,47609,-39%,"-$1,080,375",3.0,3.0,1.0,3.0,MYGN
479,D,2014-02-20 17:36:09,2014-02-19,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$13.28,34676,17165,-198%,"+$460,497",3.0,3.0,1.0,3.0,MYGN
480,D,2014-02-20 17:36:09,2014-02-19,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$34.71,-34676,17165,-67%,"-$1,203,736",3.0,3.0,1.0,3.0,MYGN
481,D,2014-02-20 17:33:53,2014-02-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$12.49,34192,17551,-205%,"+$427,217",3.0,3.0,1.0,3.0,MYGN
482,D,2014-02-20 17:33:53,2014-02-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$34.55,-34192,17551,-66%,"-$1,181,221",3.0,3.0,1.0,3.0,MYGN
483,D,2014-02-20 17:31:04,2014-02-19,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$21.48,60000,0,-100%,"+$1,288,500",3.0,3.0,1.0,3.0,MYGN
484,D,2014-02-20 17:31:04,2014-02-19,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$34.48,-60000,0,-100%,"-$2,068,620",3.0,3.0,1.0,3.0,MYGN
485,D,2014-02-20 17:27:32,2014-02-18,MYGN,Dreismann Heinrich,Dir,M - OptEx,$21.29,30000,0,-100%,"+$638,700",3.0,3.0,1.0,3.0,MYGN
486,D,2014-02-20 17:27:32,2014-02-18,MYGN,Dreismann Heinrich,Dir,S - Sale+OE,$35.00,-30000,0,-100%,"-$1,050,000",3.0,3.0,1.0,3.0,MYGN
487,D,2014-02-20 17:24:01,2014-02-18,MYGN,King Gary A.,EVP International Ops,M - OptEx,$14.88,25000,2949,-113%,"+$372,000",3.0,3.0,1.0,3.0,MYGN
488,D,2014-02-20 17:24:01,2014-02-18,MYGN,King Gary A.,EVP International Ops,S - Sale+OE,$34.74,-25000,2949,-89%,"-$868,550",3.0,3.0,1.0,3.0,MYGN
489,D,2014-02-14 17:46:40,2014-02-07,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-4196,17165,-20%,-$0,11.0,19.0,12.0,15.0,MYGN
490,D,2014-02-14 17:46:40,2014-02-14,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$7.82,20960,17165,-552%,"+$163,907",11.0,19.0,12.0,15.0,MYGN
491,D,2014-02-14 17:46:40,2014-02-14,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$31.50,-20960,17165,-55%,"-$660,223",11.0,19.0,12.0,15.0,MYGN
492,D,2014-02-12 17:41:51,2014-02-12,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$7.73,10506,324,-103%,"+$81,236",0.0,12.0,13.0,27.0,MYGN
493,D,2014-02-12 17:41:51,2014-02-12,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$30.74,-13707,324,-98%,"-$421,345",0.0,12.0,13.0,27.0,MYGN
494,D,2014-02-10 18:08:18,2014-02-10,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$17.58,87500,48268,-223%,"+$1,538,250",-3.0,-2.0,8.0,18.0,MYGN
495,D,2014-02-10 18:08:18,2014-02-10,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$32.07,-87500,48268,-64%,"-$2,805,915",-3.0,-2.0,8.0,18.0,MYGN
496,D,2014-02-10 17:14:49,2014-02-07,MYGN,Evans James S,CFO,M - OptEx,$7.82,35000,47609,+278%,"+$273,700",-3.0,-2.0,8.0,18.0,MYGN
497,D,2014-02-10 17:14:49,2014-02-07,MYGN,Evans James S,CFO,S - Sale+OE,$33.04,-35000,47609,-42%,"-$1,156,484",-3.0,-2.0,8.0,18.0,MYGN
498,D,2014-02-05 18:22:16,2014-02-05,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.01,123940,55656,-182%,"+$992,789",-2.0,-1.0,23.0,21.0,MYGN
499,D,2014-02-05 18:22:16,2014-02-05,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$31.10,-123940,55656,-69%,"-$3,854,299",-2.0,-1.0,23.0,21.0,MYGN
500,D,2013-11-08 17:06:45,2013-11-08,MYGN,Evans James S,CFO,M - OptEx,$6.00,8072,47177,+21%,"+$48,432",1.0,-3.0,-7.0,36.0,MYGN
501,D,2013-11-08 17:06:45,2013-11-08,MYGN,Evans James S,CFO,S - Sale+OE,$26.50,-8072,47177,-15%,"-$213,908",1.0,-3.0,-7.0,36.0,MYGN
502,DM,2013-11-08 16:40:54,2013-11-06,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-30502,55656,-35%,-$0,1.0,-3.0,-7.0,36.0,MYGN
503,D,2013-11-08 16:40:54,2013-11-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$5.93,31784,55656,+133%,"+$188,504",1.0,-3.0,-7.0,36.0,MYGN
504,D,2013-11-08 16:40:54,2013-11-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$26.50,-31784,55656,-36%,"-$842,332",1.0,-3.0,-7.0,36.0,MYGN
505,D,2013-06-14 17:14:56,2013-06-13,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$17.84,31498,3095,-111%,"+$561,822",-3.0,-4.0,14.0,-11.0,MYGN
506,D,2013-06-14 17:14:56,2013-06-13,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$36.17,-31498,3095,-91%,"-$1,139,379",-3.0,-4.0,14.0,-11.0,MYGN
507,D,2013-05-17 17:21:04,2013-05-16,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$17.68,79999,48268,-252%,"+$1,414,183",0.0,-2.0,-19.0,-19.0,MYGN
508,D,2013-05-17 17:21:04,2013-05-16,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$33.23,-79999,48268,-62%,"-$2,658,511",0.0,-2.0,-19.0,-19.0,MYGN
509,D,2013-05-14 17:24:09,2013-05-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$7.82,15000,85312,+21%,"+$117,300",-2.0,-3.0,-1.0,-23.0,MYGN
510,D,2013-05-14 17:24:09,2013-05-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$34.00,-15000,85312,-15%,"-$510,000",-2.0,-3.0,-1.0,-23.0,MYGN
511,DM,2013-05-10 17:10:52,2013-05-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$7.82,75960,85312,+812%,"+$594,007",0.0,0.0,3.0,-25.0,MYGN
512,DM,2013-05-10 17:10:52,2013-05-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$31.99,-75960,85312,-47%,"-$2,429,760",0.0,0.0,3.0,-25.0,MYGN
513,D,2013-05-10 17:08:49,2013-05-09,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-4000,20515,-16%,-$0,0.0,0.0,3.0,-25.0,MYGN
514,D,2013-05-10 17:08:49,2013-05-10,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$12.17,48192,20515,-174%,"+$586,497",0.0,0.0,3.0,-25.0,MYGN
515,D,2013-05-10 17:08:49,2013-05-10,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$33.00,-48192,20515,-70%,"-$1,590,563",0.0,0.0,3.0,-25.0,MYGN
516,D,2013-05-10 17:06:52,2013-05-10,MYGN,Dreismann Heinrich,Dir,M - OptEx,$18.05,30000,0,-100%,"+$541,500",0.0,0.0,3.0,-25.0,MYGN
517,D,2013-05-10 17:06:52,2013-05-10,MYGN,Dreismann Heinrich,Dir,S - Sale+OE,$31.16,-30000,0,-100%,"-$934,827",0.0,0.0,3.0,-25.0,MYGN
518,D,2012-12-11 17:13:43,2012-12-10,MYGN,Henderson John T,Dir,M - OptEx,$6.70,40000,4300,-112%,"+$267,900",-1.0,-3.0,-4.0,22.0,MYGN
519,D,2012-12-11 17:13:43,2012-12-10,MYGN,Henderson John T,Dir,S - Sale+OE,$27.65,-40000,4300,-90%,"-$1,106,193",-1.0,-3.0,-4.0,22.0,MYGN
520,D,2012-12-04 16:39:56,2012-12-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$8.63,20000,17735,-883%,"+$172,600",-1.0,-1.0,-6.0,9.0,MYGN
521,D,2012-12-04 16:39:56,2012-12-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$27.18,-20000,17735,-53%,"-$543,680",-1.0,-1.0,-6.0,9.0,MYGN
522,,2012-12-04 16:38:51,2012-11-28,MYGN,Harrison Robert Gardner,CIO,G - Gift,$0.00,-870,2307,-27%,-$0,-1.0,-1.0,-6.0,9.0,MYGN
523,,2012-12-04 16:38:51,2012-11-30,MYGN,Harrison Robert Gardner,CIO,S - Sale,$29.95,-3480,2307,-60%,"-$104,223",-1.0,-1.0,-6.0,9.0,MYGN
524,DM,2012-12-03 16:57:22,2012-11-29,MYGN,Langer Dennis,Dir,M - OptEx,$17.85,70000,0,-100%,"+$1,249,600",0.0,-2.0,-1.0,13.0,MYGN
525,DM,2012-12-03 16:57:22,2012-11-29,MYGN,Langer Dennis,Dir,S - Sale+OE,$29.88,-70000,0,-100%,"-$2,091,471",0.0,-2.0,-1.0,13.0,MYGN
526,D,2012-11-21 12:48:45,2012-11-19,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$5.89,20000,84225,+31%,"+$117,800",-1.0,-2.0,-10.0,6.0,MYGN
527,D,2012-11-21 12:48:45,2012-11-19,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$30.59,-20000,84225,-19%,"-$611,874",-1.0,-2.0,-10.0,6.0,MYGN
528,D,2012-11-21 12:46:52,2012-11-19,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$10.66,49004,17735,-157%,"+$522,465",-1.0,-2.0,-10.0,6.0,MYGN
529,D,2012-11-21 12:46:52,2012-11-19,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$30.59,-49004,17735,-73%,"-$1,499,179",-1.0,-2.0,-10.0,6.0,MYGN
530,DM,2012-11-21 12:44:22,2012-11-20,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$16.04,35324,48268,+273%,"+$566,603",-1.0,-2.0,-10.0,6.0,MYGN
531,DM,2012-11-21 12:44:22,2012-11-20,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$30.41,-35324,48268,-42%,"-$1,074,085",-1.0,-2.0,-10.0,6.0,MYGN
532,D,2012-11-13 17:12:51,2012-11-12,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$13.28,62176,48268,-447%,"+$825,697",-1.0,1.0,-9.0,11.0,MYGN
533,D,2012-11-13 17:12:51,2012-11-12,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$29.91,-62176,48268,-56%,"-$1,859,796",-1.0,1.0,-9.0,11.0,MYGN
534,DM,2012-11-13 17:09:21,2012-11-09,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$5.89,50000,84225,+146%,"+$294,500",-1.0,1.0,-9.0,11.0,MYGN
535,DM,2012-11-13 17:09:21,2012-11-09,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$29.81,-50000,84225,-37%,"-$1,490,630",-1.0,1.0,-9.0,11.0,MYGN
536,D,2012-11-08 16:24:45,2012-11-06,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-68000,84225,-45%,-$0,0.0,2.0,-7.0,12.0,MYGN
537,D,2012-11-08 16:24:45,2012-11-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$6.00,18218,84225,+28%,"+$109,308",0.0,2.0,-7.0,12.0,MYGN
538,D,2012-11-08 16:24:45,2012-11-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$29.61,-18218,84225,-18%,"-$539,364",0.0,2.0,-7.0,12.0,MYGN
539,D,2012-11-08 16:19:15,2012-11-06,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$7.82,29882,17735,-246%,"+$233,677",0.0,2.0,-7.0,12.0,MYGN
540,D,2012-11-08 16:19:15,2012-11-06,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$30.42,-29882,17735,-63%,"-$909,073",0.0,2.0,-7.0,12.0,MYGN
541,D,2012-11-08 16:15:40,2012-11-06,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$8.17,62900,24029,-162%,"+$514,136",0.0,2.0,-7.0,12.0,MYGN
542,D,2012-11-08 16:15:40,2012-11-06,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$29.05,-62900,24029,-72%,"-$1,827,000",0.0,2.0,-7.0,12.0,MYGN
543,D,2012-11-08 16:12:25,2012-11-06,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$13.91,38446,6657,-121%,"+$534,653",0.0,2.0,-7.0,12.0,MYGN
544,D,2012-11-08 16:12:25,2012-11-06,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$30.05,-38446,6657,-85%,"-$1,155,187",0.0,2.0,-7.0,12.0,MYGN
545,D,2012-11-08 16:08:41,2012-10-03,MYGN,Capone Mark Christopher,"Pres, MGL",G - Gift,$0.00,-1000,48268,-2%,-$0,0.0,2.0,-7.0,12.0,MYGN
546,D,2012-11-08 16:08:41,2012-11-06,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$12.17,27000,48268,+127%,"+$328,590",0.0,2.0,-7.0,12.0,MYGN
547,D,2012-11-08 16:08:41,2012-11-06,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$28.75,-27000,48268,-36%,"-$776,250",0.0,2.0,-7.0,12.0,MYGN
548,D,2012-10-24 17:06:35,2012-10-23,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$12.70,11132,24029,+86%,"+$141,386",0.0,3.0,18.0,6.0,MYGN
549,D,2012-10-09 10:40:09,2012-10-04,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$7.82,3900,17735,+28%,"+$30,498",-3.0,-4.0,6.0,-6.0,MYGN
550,D,2012-10-09 10:40:09,2012-10-04,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$28.50,-3900,17735,-18%,"-$111,150",-3.0,-4.0,6.0,-6.0,MYGN
551,D,2012-10-04 16:21:55,2012-10-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$7.82,3000,17735,+20%,"+$23,460",0.0,-5.0,-5.0,-14.0,MYGN
552,D,2012-10-04 16:21:55,2012-10-03,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$28.50,-3000,17735,-14%,"-$85,500",0.0,-5.0,-5.0,-14.0,MYGN
553,D,2012-10-03 17:09:33,2012-10-02,MYGN,Evans James S,CFO,M - OptEx,$5.89,35000,46771,+297%,"+$206,150",0.0,-5.0,-5.0,-13.0,MYGN
554,D,2012-10-03 17:09:33,2012-10-02,MYGN,Evans James S,CFO,S - Sale+OE,$28.06,-35000,46771,-43%,"-$982,195",0.0,-5.0,-5.0,-13.0,MYGN
555,D,2012-09-28 17:42:45,2012-09-28,MYGN,Evans James S,CFO,M - OptEx,$4.44,26250,46771,+128%,"+$116,550",2.0,5.0,-3.0,-10.0,MYGN
556,D,2012-09-28 17:42:45,2012-09-28,MYGN,Evans James S,CFO,S - Sale+OE,$26.99,-26250,46771,-36%,"-$708,396",2.0,5.0,-3.0,-10.0,MYGN
557,,2012-09-19 16:05:03,2012-09-17,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale,$28.00,-5000,17735,-22%,"-$140,000",0.0,-4.0,-1.0,-8.0,MYGN
558,D,2012-09-14 16:28:47,2012-09-11,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-2952,12897,-19%,-$0,1.0,0.0,-2.0,-8.0,MYGN
559,D,2012-09-14 16:22:34,2012-09-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$6.00,20000,152225,+15%,"+$120,000",1.0,0.0,-2.0,-8.0,MYGN
560,D,2012-09-14 16:22:34,2012-09-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$27.60,-20000,152225,-12%,"-$552,008",1.0,0.0,-2.0,-8.0,MYGN
561,D,2012-09-14 16:19:26,2012-09-13,MYGN,Evans James S,CFO,M - OptEx,$3.80,5494,46771,+13%,"+$20,877",1.0,0.0,-2.0,-8.0,MYGN
562,D,2012-09-14 16:19:26,2012-09-13,MYGN,Evans James S,CFO,S - Sale+OE,$27.10,-5494,46771,-11%,"-$148,887",1.0,0.0,-2.0,-8.0,MYGN
563,D,2012-09-12 16:55:48,2012-08-20,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-34000,152225,-18%,-$0,0.0,2.0,0.0,-4.0,MYGN
564,D,2012-09-12 16:55:48,2012-09-11,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$6.00,20000,152225,+15%,"+$119,997",0.0,2.0,0.0,-4.0,MYGN
565,D,2012-09-12 16:55:48,2012-09-11,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$26.92,-20000,152225,-12%,"-$538,492",0.0,2.0,0.0,-4.0,MYGN
566,D,2012-09-12 16:54:19,2012-09-10,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$8.95,19805,49268,+67%,"+$177,213",0.0,2.0,0.0,-4.0,MYGN
567,D,2012-09-12 16:54:19,2012-09-10,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$27.00,-19805,49268,-29%,"-$534,735",0.0,2.0,0.0,-4.0,MYGN
568,DM,2012-09-12 16:52:50,2012-09-10,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$7.82,19300,15849,-559%,"+$150,926",0.0,2.0,0.0,-4.0,MYGN
569,DM,2012-09-12 16:52:50,2012-09-10,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$27.00,-19300,15849,-55%,"-$521,114",0.0,2.0,0.0,-4.0,MYGN
570,DM,2012-09-12 16:51:19,2012-09-10,MYGN,Evans James S,CFO,M - OptEx,$3.80,24506,46771,+110%,"+$93,123",0.0,2.0,0.0,-4.0,MYGN
571,DM,2012-09-12 16:51:19,2012-09-10,MYGN,Evans James S,CFO,S - Sale+OE,$27.01,-24506,46771,-34%,"-$661,855",0.0,2.0,0.0,-4.0,MYGN
572,DM,2012-08-21 17:55:41,2012-08-20,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$13.03,60000,0,-100%,"+$781,800",-3.0,-4.0,7.0,-2.0,MYGN
573,DM,2012-08-21 17:55:41,2012-08-20,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$25.99,-60000,0,-100%,"-$1,559,206",-3.0,-4.0,7.0,-2.0,MYGN
574,D,2012-08-03 16:28:59,2012-08-01,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$13.28,5324,186225,+3%,"+$70,703",1.0,2.0,1.0,10.0,MYGN
575,D,2012-07-18 16:21:16,2012-07-18,MYGN,Evans James S,CFO,M - OptEx,$8.68,15400,46771,+49%,"+$133,672",0.0,-2.0,-4.0,6.0,MYGN
576,D,2012-07-18 16:21:16,2012-07-18,MYGN,Evans James S,CFO,S - Sale+OE,$26.01,-15400,46771,-25%,"-$400,605",0.0,-2.0,-4.0,6.0,MYGN
577,D,2012-07-13 16:50:37,2012-07-13,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.68,1478,180901,+1%,"+$12,829",-1.0,1.0,-1.0,6.0,MYGN
578,D,2012-07-13 16:50:37,2012-07-13,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$25.90,-1478,180901,-1%,"-$38,280",-1.0,1.0,-1.0,6.0,MYGN
579,DM,2012-07-11 16:06:12,2012-07-09,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.68,28522,180901,+19%,"+$247,571",1.0,0.0,-2.0,5.0,MYGN
580,DM,2012-07-11 16:06:12,2012-07-09,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$25.72,-28522,180901,-14%,"-$733,657",1.0,0.0,-2.0,5.0,MYGN
581,D,2012-05-04 16:30:33,2012-05-02,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$8.99,4257,49268,+9%,"+$38,258",0.0,-1.0,-12.0,3.0,MYGN
582,D,2012-05-04 16:30:33,2012-05-02,MYGN,Capone Mark Christopher,"Pres, MGL",S - Sale+OE,$27.00,-4257,49268,-8%,"-$114,939",0.0,-1.0,-12.0,3.0,MYGN
583,D,2012-05-04 16:26:07,2012-05-02,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$7.82,700,15201,+5%,"+$5,474",0.0,-1.0,-12.0,3.0,MYGN
584,D,2012-05-04 16:26:07,2012-05-02,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$27.00,-700,15201,-4%,"-$18,900",0.0,-1.0,-12.0,3.0,MYGN
585,DM,2012-04-27 17:09:34,2012-04-26,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$4.44,39040,180901,+28%,"+$173,338",-3.0,-1.0,-4.0,-3.0,MYGN
586,DM,2012-04-27 17:09:34,2012-04-26,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$26.27,-39040,180901,-18%,"-$1,025,573",-3.0,-1.0,-4.0,-3.0,MYGN
587,D,2012-04-27 17:07:47,2012-04-26,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$7.82,20000,15201,-417%,"+$156,400",-3.0,-1.0,-4.0,-3.0,MYGN
588,D,2012-04-27 17:07:47,2012-04-26,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$26.03,-20000,15201,-57%,"-$520,574",-3.0,-1.0,-4.0,-3.0,MYGN
589,D,2012-04-24 17:13:26,2012-04-20,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$4.44,40000,180901,+28%,"+$177,600",3.0,3.0,2.0,3.0,MYGN
590,D,2012-04-24 17:13:26,2012-04-20,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$25.42,-40000,180901,-18%,"-$1,016,808",3.0,3.0,2.0,3.0,MYGN
591,D,2012-04-12 17:44:51,2012-02-03,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-7000,15201,-32%,-$0,-1.0,-1.0,7.0,13.0,MYGN
592,D,2012-04-12 17:44:51,2012-04-10,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$8.63,8196,15201,+117%,"+$70,731",-1.0,-1.0,7.0,13.0,MYGN
593,D,2012-03-16 16:20:41,2012-03-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.68,10000,180901,+6%,"+$86,800",1.0,-10.0,-6.0,7.0,MYGN
594,D,2012-03-16 16:20:41,2012-03-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$24.94,-10000,180901,-5%,"-$249,432",1.0,-10.0,-6.0,7.0,MYGN
595,D,2012-03-16 16:18:19,2012-03-15,MYGN,Evans James S,CFO,M - OptEx,$8.68,4600,45598,+11%,"+$39,928",1.0,-10.0,-6.0,7.0,MYGN
596,D,2012-03-16 16:18:19,2012-03-15,MYGN,Evans James S,CFO,S - Sale+OE,$25.01,-4600,45598,-9%,"-$115,026",1.0,-10.0,-6.0,7.0,MYGN
597,DM,2012-03-16 16:13:39,2012-03-15,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$9.04,30000,22735,-413%,"+$271,200",1.0,-10.0,-6.0,7.0,MYGN
598,DM,2012-03-16 16:13:39,2012-03-15,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$25.00,-30000,22735,-57%,"-$750,103",1.0,-10.0,-6.0,7.0,MYGN
599,D,2012-03-16 16:10:33,2012-03-15,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$8.26,36000,5894,-120%,"+$297,184",1.0,-10.0,-6.0,7.0,MYGN
600,D,2012-03-16 16:10:33,2012-03-15,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$24.99,-36000,5894,-86%,"-$899,527",1.0,-10.0,-6.0,7.0,MYGN
601,D,2012-03-08 18:28:02,2012-03-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$6.62,17296,180901,+11%,"+$114,525",1.0,2.0,-3.0,8.0,MYGN
602,D,2012-03-08 18:28:02,2012-03-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$24.51,-17296,180901,-9%,"-$423,955",1.0,2.0,-3.0,8.0,MYGN
603,D,2012-02-28 16:26:37,2012-02-27,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$6.22,53021,14005,-136%,"+$329,741",-1.0,-1.0,-4.0,2.0,MYGN
604,D,2012-02-28 16:26:37,2012-02-27,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$23.99,-53021,14005,-79%,"-$1,272,037",-1.0,-1.0,-4.0,2.0,MYGN
605,DM,2012-02-17 16:07:14,2012-02-16,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$10.02,30276,180901,+20%,"+$303,489",-2.0,0.0,8.0,2.0,MYGN
606,DM,2012-02-17 16:07:14,2012-02-16,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$23.78,-30296,180901,-14%,"-$720,416",-2.0,0.0,8.0,2.0,MYGN
607,D,2012-02-17 16:05:00,2012-02-15,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$12.64,2204,5894,+60%,"+$27,859",-2.0,0.0,8.0,2.0,MYGN
608,D,2012-02-17 16:05:00,2012-02-15,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$23.40,-2204,5894,-27%,"-$51,574",-2.0,0.0,8.0,2.0,MYGN
609,D,2012-02-09 17:11:20,2012-02-07,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$12.64,6500,180921,+4%,"+$82,160",0.0,0.0,6.0,7.0,MYGN
610,D,2012-02-09 17:11:20,2012-02-07,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$24.00,-6500,180921,-3%,"-$156,000",0.0,0.0,6.0,7.0,MYGN
611,D,2012-02-09 17:06:23,2011-12-02,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-1000,14005,-7%,-$0,0.0,0.0,6.0,7.0,MYGN
612,D,2012-02-09 17:06:23,2012-02-07,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$5.89,6019,14005,+75%,"+$35,452",0.0,0.0,6.0,7.0,MYGN
613,D,2012-02-09 17:06:23,2012-02-07,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$24.02,-12686,14005,-48%,"-$304,750",0.0,0.0,6.0,7.0,MYGN
614,DM,2012-02-07 17:23:21,2012-02-03,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$12.64,53222,180921,+42%,"+$672,726",-2.0,-2.0,0.0,4.0,MYGN
615,DM,2012-02-07 17:23:21,2012-02-03,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$23.97,-53222,180921,-23%,"-$1,275,569",-2.0,-2.0,0.0,4.0,MYGN
616,DM,2012-02-07 17:20:50,2012-02-03,MYGN,Evans James S,CFO,M - OptEx,$12.64,8800,45598,+24%,"+$111,232",-2.0,-2.0,0.0,4.0,MYGN
617,DM,2012-02-07 17:20:50,2012-02-03,MYGN,Evans James S,CFO,S - Sale+OE,$23.98,-8800,45598,-16%,"-$211,028",-2.0,-2.0,0.0,4.0,MYGN
618,DM,2012-02-02 16:20:19,2012-01-31,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$3.80,30200,180921,+20%,"+$114,760",1.0,0.0,3.0,3.0,MYGN
619,DM,2012-02-02 16:20:19,2012-01-31,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$23.95,-30200,180921,-14%,"-$723,234",1.0,0.0,3.0,3.0,MYGN
620,D,2012-02-02 16:12:50,2012-02-01,MYGN,Lanchbury Jerry S,Chief Scientific Officer,D - Sale to issuer,$24.15,-6000,22735,-21%,"-$144,924",1.0,0.0,3.0,3.0,MYGN
621,D,2012-02-02 16:12:50,2011-12-09,MYGN,Lanchbury Jerry S,Chief Scientific Officer,G - Gift,$0.00,-466,22735,-2%,-$0,1.0,0.0,3.0,3.0,MYGN
622,D,2012-02-02 16:12:50,2012-02-01,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$8.63,21804,22735,>999%,"+$188,169",1.0,0.0,3.0,3.0,MYGN
623,D,2012-02-02 16:12:50,2012-02-01,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$24.05,-21804,22735,-49%,"-$524,338",1.0,0.0,3.0,3.0,MYGN
624,DM,2012-01-27 16:56:51,2012-01-25,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$3.80,15000,180921,+9%,"+$57,000",0.0,2.0,3.0,12.0,MYGN
625,DM,2012-01-27 16:56:51,2012-01-25,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$23.04,-15000,180921,-8%,"-$345,637",0.0,2.0,3.0,12.0,MYGN
626,D,2011-08-29 17:10:19,2011-08-25,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$12.17,5808,180921,+3%,"+$70,683",-1.0,-8.0,-6.0,22.0,MYGN
627,D,2011-06-16 16:35:59,2011-06-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$20.24,20000,175093,+13%,"+$404,800",-1.0,-1.0,2.0,-14.0,MYGN
628,D,2011-06-16 16:35:59,2011-06-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$23.99,-20000,175093,-10%,"-$479,760",-1.0,-1.0,2.0,-14.0,MYGN
629,,2011-06-07 17:43:28,2011-06-07,MYGN,Best Lawrence C,Dir,D - Sale to issuer,$24.58,-100000,0,-100%,"-$2,458,150",0.0,-1.0,-5.0,-13.0,MYGN
630,D,2011-06-07 16:58:01,2011-06-06,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$8.63,5000,29201,+21%,"+$43,150",0.0,-1.0,-5.0,-13.0,MYGN
631,D,2011-05-26 18:36:58,2011-05-25,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$20.24,20000,173926,+13%,"+$404,800",1.0,-1.0,-11.0,-22.0,MYGN
632,D,2011-05-26 18:36:58,2011-05-25,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$25.00,-20000,173926,-10%,"-$500,000",1.0,-1.0,-11.0,-22.0,MYGN
633,D,2011-05-19 16:17:25,2011-05-18,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$20.24,20000,173926,+13%,"+$404,800",-1.0,-1.0,-10.0,-18.0,MYGN
634,D,2011-05-19 16:17:25,2011-05-18,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$24.67,-20000,173926,-10%,"-$493,390",-1.0,-1.0,-10.0,-18.0,MYGN
635,D,2011-05-19 15:05:21,2011-05-18,MYGN,Evans James S,CFO,M - OptEx,$23.53,5000,44411,+13%,"+$117,650",1.0,0.0,-9.0,-17.0,MYGN
636,D,2011-05-19 15:05:21,2011-05-18,MYGN,Evans James S,CFO,S - Sale+OE,$24.65,-5000,44411,-10%,"-$123,251",1.0,0.0,-9.0,-17.0,MYGN
637,D,2011-05-19 11:57:56,2011-05-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,M - OptEx,$6.93,44314,24201,-220%,"+$307,235",1.0,0.0,-9.0,-17.0,MYGN
638,D,2011-05-19 11:57:56,2011-05-18,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale+OE,$25.00,-44314,24201,-65%,"-$1,108,027",1.0,0.0,-9.0,-17.0,MYGN
639,D,2011-05-16 13:01:59,2011-05-12,MYGN,Evans James S,CFO,M - OptEx,$23.53,5000,44411,+13%,"+$117,650",0.0,3.0,0.0,-16.0,MYGN
640,D,2011-05-16 13:01:59,2011-05-12,MYGN,Evans James S,CFO,S - Sale+OE,$24.50,-5000,44411,-10%,"-$122,500",0.0,3.0,0.0,-16.0,MYGN
641,DM,2011-05-12 09:11:10,2011-05-04,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-7444,20796,-26%,-$0,1.0,3.0,0.0,-14.0,MYGN
642,D,2011-05-12 09:11:10,2011-05-09,MYGN,Marsh Richard M,"E.VP, GC",M - OptEx,$5.97,69300,20796,-143%,"+$413,600",1.0,3.0,0.0,-14.0,MYGN
643,D,2011-05-12 09:11:10,2011-05-09,MYGN,Marsh Richard M,"E.VP, GC",S - Sale+OE,$23.21,-69300,20796,-77%,"-$1,608,206",1.0,3.0,0.0,-14.0,MYGN
644,DM,2011-05-12 09:09:44,2011-05-09,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$21.60,20000,4674,-130%,"+$432,040",1.0,3.0,0.0,-14.0,MYGN
645,DM,2011-05-12 09:09:44,2011-05-09,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$23.08,-20000,4674,-81%,"-$461,674",1.0,3.0,0.0,-14.0,MYGN
646,,2011-05-04 16:34:01,2011-05-04,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale,$22.75,-5300,24201,-18%,"-$120,575",1.0,6.0,12.0,-5.0,MYGN
647,,2011-05-02 12:00:49,2011-04-29,MYGN,Lanchbury Jerry S,Chief Scientific Officer,S - Sale,$22.00,-4700,29501,-14%,"-$103,416",0.0,6.0,19.0,1.0,MYGN
648,D,2011-02-24 17:41:07,2010-11-29,MYGN,Lanchbury Jerry S,Chief Scientific Officer,G - Gift,$0.00,-703,34201,-2%,-$0,-1.0,4.0,5.0,4.0,MYGN
649,DM,2011-02-24 17:35:33,2010-10-13,MYGN,Marsh Richard M,"E.VP, GC",G - Gift,$0.00,-5333,28240,-16%,-$0,-1.0,4.0,5.0,4.0,MYGN
650,D,2011-02-24 17:28:59,2010-12-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-37500,173926,-18%,-$0,-1.0,4.0,5.0,4.0,MYGN
651,M,2010-12-01 17:52:07,2010-11-30,MYGN,Best Lawrence C,Dir,S - Sale,$21.54,-90000,100000,-47%,"-$1,938,283",1.0,0.0,7.0,18.0,MYGN
652,D,2010-07-14 11:11:05,2010-07-12,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$8.63,5000,50268,+11%,"+$43,150",0.0,-3.0,-4.0,33.0,MYGN
653,D,2010-05-11 17:21:49,2010-05-10,MYGN,Capone Mark Christopher,"Pres, MGL",M - OptEx,$9.04,2814,45268,+7%,"+$25,439",2.0,4.0,-2.0,15.0,MYGN
654,D,2010-05-10 19:01:23,2010-05-07,MYGN,Evans James S,CFO,M - OptEx,$4.44,8750,43041,+26%,"+$38,850",0.0,4.0,-2.0,16.0,MYGN
655,D,2010-05-10 18:22:38,2010-05-07,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.63,8196,210025,+4%,"+$70,731",0.0,4.0,-2.0,16.0,MYGN
656,D,2010-05-10 18:15:38,2010-05-07,MYGN,Evans James S,CFO,M - OptEx,$4.44,8750,43041,+26%,"+$38,850",0.0,4.0,-2.0,16.0,MYGN
657,DM,2010-03-12 16:35:58,2010-03-11,MYGN,Evans James S,CFO,M - OptEx,$8.86,8400,34291,+32%,"+$74,424",4.0,3.0,-6.0,-35.0,MYGN
658,DM,2010-03-12 16:35:58,2010-03-11,MYGN,Evans James S,CFO,S - Sale+OE,$23.95,-8400,34291,-20%,"-$201,180",4.0,3.0,-6.0,-35.0,MYGN
659,D,2010-03-08 17:40:07,2010-03-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.86,30754,201829,+18%,"+$272,480",1.0,8.0,3.0,-29.0,MYGN
660,D,2010-03-08 17:40:07,2010-03-08,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$22.30,-30754,201829,-13%,"-$685,857",1.0,8.0,3.0,-29.0,MYGN
661,DM,2010-03-05 16:43:37,2010-03-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$8.86,46322,201829,+30%,"+$410,413",1.0,5.0,7.0,-28.0,MYGN
662,DM,2010-03-05 16:43:37,2010-03-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$22.97,-46322,201829,-19%,"-$1,064,234",1.0,5.0,7.0,-28.0,MYGN
663,D,2010-02-19 16:07:21,2010-02-18,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$7.66,7000,42454,+20%,"+$53,610",0.0,1.0,13.0,-27.0,MYGN
664,DM,2010-01-14 12:03:42,2009-10-30,MYGN,Marsh Richard M,"VP, GC",G - Gift,$0.00,-4500,32534,-12%,-$0,-1.0,-7.0,-13.0,-36.0,MYGN
665,D,2010-01-14 12:03:42,2010-01-12,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$7.27,9726,32534,+43%,"+$70,708",-1.0,-7.0,-13.0,-36.0,MYGN
666,D,2010-01-08 16:36:55,2010-01-07,MYGN,Wilson Linda S,Dir,M - OptEx,$10.32,28000,2500,-110%,"+$289,050",-2.0,-6.0,-17.0,-42.0,MYGN
667,D,2010-01-08 16:36:55,2010-01-07,MYGN,Wilson Linda S,Dir,S - Sale+OE,$26.90,-30500,2500,-92%,"-$820,581",-2.0,-6.0,-17.0,-42.0,MYGN
668,D,2010-01-08 11:09:13,2010-01-07,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$7.27,14904,34904,+75%,"+$108,352",-1.0,-8.0,-18.0,-43.0,MYGN
669,,2009-12-23 18:11:06,2009-12-23,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale,$26.01,-26428,20000,-57%,"-$687,419",0.0,1.0,-15.0,-42.0,MYGN
670,D,2009-12-14 16:12:45,2009-12-11,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$7.27,9726,201829,+5%,"+$70,708",1.0,-1.0,1.0,-26.0,MYGN
671,D,2009-11-06 12:19:38,2009-10-28,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,138274,743207,-16%,+$0,0.0,-2.0,-1.0,-26.0,MYGN
672,DM,2009-11-06 12:19:38,2009-11-04,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$16.37,65000,743207,+10%,"+$1,064,200",0.0,-2.0,-1.0,-26.0,MYGN
673,DM,2009-11-06 12:19:38,2009-11-04,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$25.44,-192000,743207,-21%,"-$4,884,261",0.0,-2.0,-1.0,-26.0,MYGN
674,D,2009-09-17 11:56:54,2009-08-28,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-28713,192103,-13%,-$0,2.0,-6.0,-10.0,-17.0,MYGN
675,D,2009-09-10 16:26:59,2009-09-10,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$10.66,13196,2540,-124%,"+$140,661",0.0,-3.0,-12.0,-23.0,MYGN
676,D,2009-09-10 16:26:59,2009-09-10,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$31.11,-13196,2540,-84%,"-$410,525",0.0,-3.0,-12.0,-23.0,MYGN
677,D,2009-08-31 15:15:17,2009-08-28,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$8.86,46682,129546,+56%,"+$413,603",0.0,1.0,-11.0,-22.0,MYGN
678,D,2009-08-31 15:15:17,2009-08-28,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$30.75,-46682,129546,-26%,"-$1,435,378",0.0,1.0,-11.0,-22.0,MYGN
679,D,2009-07-14 15:35:13,2009-07-13,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$7.27,15000,35454,+73%,"+$109,050",1.0,4.0,6.0,3.0,MYGN
680,D,2009-06-08 17:30:10,2009-06-08,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$10.76,37158,234071,+19%,"+$399,950",3.0,5.0,-24.0,-25.0,MYGN
681,D,2009-05-29 15:58:24,2009-05-27,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$2.39,40000,195726,+26%,"+$95,620",3.0,5.0,3.0,-26.0,MYGN
682,D,2009-05-29 15:58:24,2009-05-27,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$34.01,-40000,195726,-17%,"-$1,360,568",3.0,5.0,3.0,-26.0,MYGN
683,,2009-05-14 11:07:52,2009-05-13,MYGN,Henderson John T,Dir,P - Purchase,$32.73,300,4300,+8%,"+$9,820",0.0,3.0,17.0,-19.0,MYGN
684,D,2009-05-11 16:14:11,2009-05-08,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$10.28,5000,46428,+12%,"+$51,400",1.0,1.0,15.0,-18.0,MYGN
685,DM,2009-05-11 16:11:59,2009-03-02,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,64962,967962,-6%,+$0,1.0,1.0,15.0,-18.0,MYGN
686,DM,2009-05-11 16:11:59,2009-05-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$2.39,21992,967962,+2%,"+$52,572",1.0,1.0,15.0,-18.0,MYGN
687,DM,2009-05-11 16:11:59,2009-05-07,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$32.36,-21992,967962,-2%,"-$711,654",1.0,1.0,15.0,-18.0,MYGN
688,D,2009-05-11 16:09:58,2009-05-08,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$12.53,2636,127648,+2%,"+$33,033",1.0,1.0,15.0,-18.0,MYGN
689,D,2009-05-11 16:07:50,2009-05-08,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.64,17742,195726,+10%,"+$99,991",1.0,1.0,15.0,-18.0,MYGN
690,D,2009-05-11 16:06:06,2009-05-08,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$10.28,29178,44260,+193%,"+$299,950",1.0,1.0,15.0,-18.0,MYGN
691,,2009-05-07 17:30:40,2009-05-07,MYGN,Belle Gerald P.,Dir,P - Purchase,$32.50,1000,1200,+500%,"+$32,500",-5.0,1.0,15.0,-12.0,MYGN
692,D,2009-04-07 16:05:23,2009-04-06,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$18.19,36000,20454,-232%,"+$654,953",4.0,4.0,-25.0,-32.0,MYGN
693,D,2009-04-07 16:05:23,2009-04-06,MYGN,Capone Mark Christopher,"COO, MGL",S - Sale+OE,$43.07,-36000,20454,-64%,"-$1,550,475",4.0,4.0,-25.0,-32.0,MYGN
694,D,2009-03-27 17:50:50,2009-03-26,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$8.49,20000,41428,+93%,"+$169,700",2.0,-1.0,-14.0,-32.0,MYGN
695,D,2009-03-27 17:50:50,2009-03-26,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$46.74,-20000,41428,-33%,"-$934,800",2.0,-1.0,-14.0,-32.0,MYGN
696,D,2009-03-27 17:49:02,2009-03-27,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$9.75,24000,15082,-269%,"+$234,000",2.0,-1.0,-14.0,-32.0,MYGN
697,D,2009-03-27 17:49:02,2009-03-27,MYGN,Laslie W Wayne,"COO, MPI",S - Sale+OE,$44.96,-24000,15082,-61%,"-$1,079,040",2.0,-1.0,-14.0,-32.0,MYGN
698,D,2009-03-04 17:11:32,2009-03-04,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$4.78,2000,498825,0%,"+$9,562",-3.0,3.0,14.0,-16.0,MYGN
699,D,2009-03-04 17:11:32,2009-03-04,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$79.00,-2000,498825,0%,"-$158,000",-3.0,3.0,14.0,-16.0,MYGN
700,D,2009-03-03 11:40:37,2009-03-02,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$20.56,2500,20714,+14%,"+$51,400",5.0,3.0,20.0,-11.0,MYGN
701,D,2009-03-02 16:19:19,2009-02-27,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$4.78,9000,498825,+2%,"+$43,029",2.0,3.0,19.0,-11.0,MYGN
702,D,2009-03-02 16:19:19,2009-02-27,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$80.36,-9000,498825,-2%,"-$723,240",2.0,3.0,19.0,-11.0,MYGN
703,D,2009-02-24 18:12:18,2009-02-23,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$15.28,7227,10227,+241%,"+$110,429",-1.0,-8.0,-1.0,-33.0,MYGN
704,D,2009-02-24 18:11:07,2009-02-23,MYGN,Evans James S,CFO,M - OptEx,$5.56,7920,16338,+94%,"+$44,055",-1.0,-8.0,-1.0,-33.0,MYGN
705,D,2009-02-24 18:09:57,2009-02-23,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$20.56,4863,109459,+5%,"+$99,983",-1.0,-8.0,-1.0,-33.0,MYGN
706,D,2009-02-20 17:16:17,2009-02-04,MYGN,Marsh Richard M,"VP, GC",G - Gift,$0.00,-1600,12937,-11%,-$0,-4.0,-3.0,-6.0,-34.0,MYGN
707,D,2009-02-20 17:14:42,2008-12-22,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-300,498825,0%,-$0,-4.0,-3.0,-6.0,-34.0,MYGN
708,D,2009-02-11 16:47:47,2009-02-09,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$29.35,15812,3000,-123%,"+$464,118",1.0,-1.0,-4.0,-32.0,MYGN
709,D,2009-02-11 16:47:47,2009-02-09,MYGN,Capone Mark Christopher,"COO, MGL",S - Sale+OE,$85.40,-21893,3000,-88%,"-$1,869,638",1.0,-1.0,-4.0,-32.0,MYGN
710,D,2009-02-06 17:09:59,2009-02-06,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$21.67,10000,18214,+122%,"+$216,659",2.0,4.0,-8.0,-33.0,MYGN
711,D,2009-02-06 17:09:59,2009-02-06,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$84.31,-10000,18214,-35%,"-$843,080",2.0,4.0,-8.0,-33.0,MYGN
712,D,2009-02-05 16:26:07,2009-02-05,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$4.78,24000,88992,+37%,"+$114,744",1.0,3.0,-7.0,-31.0,MYGN
713,D,2009-02-05 16:26:07,2009-02-05,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$83.60,-24000,88992,-21%,"-$2,006,366",1.0,3.0,-7.0,-31.0,MYGN
714,D,2009-02-05 16:24:43,2009-02-03,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$16.64,20000,62506,+47%,"+$332,800",1.0,3.0,-7.0,-31.0,MYGN
715,D,2009-02-05 16:24:43,2009-02-03,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$84.50,-20000,62506,-24%,"-$1,690,000",1.0,3.0,-7.0,-31.0,MYGN
716,D,2009-02-05 16:23:00,2009-02-05,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$25.06,15000,104596,+17%,"+$375,938",1.0,3.0,-7.0,-31.0,MYGN
717,DM,2009-02-05 16:23:00,2009-02-03,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$83.09,-25000,104596,-19%,"-$2,077,203",1.0,3.0,-7.0,-31.0,MYGN
718,D,2009-02-05 16:20:50,2009-02-03,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$16.64,10000,18214,+122%,"+$166,400",1.0,3.0,-7.0,-31.0,MYGN
719,D,2009-02-05 16:20:50,2009-02-03,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$82.00,-10000,18214,-35%,"-$820,000",1.0,3.0,-7.0,-31.0,MYGN
720,D,2009-02-05 16:19:08,2009-02-03,MYGN,Evans James S,CFO,M - OptEx,$16.97,10964,8418,-431%,"+$186,059",1.0,3.0,-7.0,-31.0,MYGN
721,D,2009-02-05 16:19:08,2009-02-03,MYGN,Evans James S,CFO,S - Sale+OE,$80.01,-10964,8418,-57%,"-$877,181",1.0,3.0,-7.0,-31.0,MYGN
722,D,2009-02-05 16:17:24,2009-02-05,MYGN,Henderson John T,Dir,M - OptEx,$17.23,10000,2000,-125%,"+$172,300",1.0,3.0,-7.0,-31.0,MYGN
723,D,2009-02-05 16:17:24,2009-02-05,MYGN,Henderson John T,Dir,S - Sale+OE,$82.46,-10000,2000,-83%,"-$824,582",1.0,3.0,-7.0,-31.0,MYGN
724,D,2009-02-05 16:15:43,2009-02-05,MYGN,Langer Dennis,Dir,M - OptEx,$27.15,15000,0,-100%,"+$407,250",1.0,3.0,-7.0,-31.0,MYGN
725,D,2009-02-05 16:15:43,2009-02-05,MYGN,Langer Dennis,Dir,S - Sale+OE,$82.72,-15000,0,-100%,"-$1,240,731",1.0,3.0,-7.0,-31.0,MYGN
726,D,2009-02-05 16:13:57,2009-02-03,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$14.53,4000,810,-125%,"+$58,112",1.0,3.0,-7.0,-31.0,MYGN
727,D,2009-02-05 16:13:57,2009-02-03,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$82.50,-4000,810,-83%,"-$330,000",1.0,3.0,-7.0,-31.0,MYGN
728,DM,2009-02-04 18:18:51,2009-02-02,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$18.69,15863,14537,-1196%,"+$296,443",1.0,4.0,-7.0,-29.0,MYGN
729,DM,2009-02-04 18:18:51,2009-02-03,MYGN,Marsh Richard M,"VP, GC",S - Sale+OE,$85.00,-11000,14537,-43%,"-$935,000",1.0,4.0,-7.0,-29.0,MYGN
730,DM,2009-01-30 16:34:28,2008-11-05,MYGN,Marsh Richard M,"VP, GC",G - Gift,$0.00,-9600,9674,>999%,-$0,-4.0,12.0,1.0,-19.0,MYGN
731,DM,2009-01-30 16:34:28,2009-01-29,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$17.86,11604,9674,-601%,"+$207,247",-4.0,12.0,1.0,-19.0,MYGN
732,DM,2009-01-30 16:34:28,2009-01-29,MYGN,Marsh Richard M,"VP, GC",S - Sale+OE,$75.04,-11604,9674,-55%,"-$870,727",-4.0,12.0,1.0,-19.0,MYGN
733,D,2009-01-30 16:32:57,2008-12-23,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,G - Gift,$0.00,-4615,62506,-7%,-$0,-4.0,12.0,1.0,-19.0,MYGN
734,DM,2009-01-30 16:32:57,2009-01-28,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$11.76,34000,62506,+119%,"+$399,734",-4.0,12.0,1.0,-19.0,MYGN
735,D,2009-01-30 16:32:57,2009-01-28,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$74.50,-20000,62506,-24%,"-$1,490,000",-4.0,12.0,1.0,-19.0,MYGN
736,D,2009-01-07 15:42:19,2009-01-06,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$20.56,5000,18214,+38%,"+$102,800",-1.0,2.0,23.0,-20.0,MYGN
737,D,2008-12-18 16:08:12,2008-12-18,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$18.77,10000,13214,+311%,"+$187,650",-1.0,-2.0,7.0,19.0,MYGN
738,D,2008-12-18 16:08:12,2008-12-18,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$67.00,-10000,13214,-43%,"-$670,000",-1.0,-2.0,7.0,19.0,MYGN
739,D,2008-12-11 17:41:18,2008-12-11,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$4.78,20000,88992,+29%,"+$95,620",2.0,8.0,12.0,25.0,MYGN
740,D,2008-12-11 17:41:18,2008-12-11,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$60.60,-20000,88992,-18%,"-$1,212,066",2.0,8.0,12.0,25.0,MYGN
741,D,2008-12-10 13:21:17,2008-12-09,MYGN,Wilson Linda S,Dir,M - OptEx,$34.57,16000,2500,-119%,"+$553,120",-4.0,3.0,6.0,21.0,MYGN
742,D,2008-12-10 13:21:17,2008-12-09,MYGN,Wilson Linda S,Dir,S - Sale+OE,$63.91,-16000,2500,-86%,"-$1,022,618",-4.0,3.0,6.0,21.0,MYGN
743,D,2008-11-25 16:17:13,2008-11-21,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$19.50,5128,7541,+213%,"+$99,996",1.0,-2.0,7.0,16.0,MYGN
744,D,2008-11-12 16:39:31,2008-11-10,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$4.78,10000,499125,+2%,"+$47,810",8.0,3.0,-5.0,1.0,MYGN
745,D,2008-11-12 16:39:31,2008-11-10,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$71.15,-10000,499125,-2%,"-$711,500",8.0,3.0,-5.0,1.0,MYGN
746,D,2008-11-06 16:21:06,2008-11-04,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$19.50,12000,2413,-125%,"+$234,000",0.0,-10.0,-12.0,-14.0,MYGN
747,D,2008-11-06 16:21:06,2008-11-04,MYGN,Laslie W Wayne,"COO, MPI",S - Sale+OE,$70.00,-12000,2413,-83%,"-$840,000",0.0,-10.0,-12.0,-14.0,MYGN
748,,2008-11-06 16:17:50,2008-11-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-13000,114596,-10%,-$0,0.0,-10.0,-12.0,-14.0,MYGN
749,,2008-11-06 16:17:50,2008-11-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$70.37,-10000,114596,-8%,"-$703,718",0.0,-10.0,-12.0,-14.0,MYGN
750,D,2008-09-30 18:09:38,2008-09-29,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,21068,88992,+31%,"+$107,974",1.0,-8.0,-13.0,40.0,MYGN
751,,2008-09-29 18:18:44,2008-09-25,MYGN,Evans James S,CFO,S - Sale,$69.00,-6669,8418,-44%,"-$460,161",0.0,-4.0,-17.0,38.0,MYGN
752,D,2008-09-25 18:38:27,2008-09-23,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,10000,67924,+17%,"+$51,250",0.0,-4.0,-13.0,34.0,MYGN
753,D,2008-09-25 18:38:27,2008-09-25,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$68.54,-15000,67924,-18%,"-$1,028,138",0.0,-4.0,-13.0,34.0,MYGN
754,D,2008-09-23 17:49:45,2008-09-19,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,992,72924,+1%,"+$5,084",5.0,3.0,-1.0,29.0,MYGN
755,D,2008-09-23 17:49:45,2008-09-19,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$66.00,-992,72924,-1%,"-$65,472",5.0,3.0,-1.0,29.0,MYGN
756,D,2008-09-19 16:50:45,2008-09-19,MYGN,Wilson Linda S,Dir,M - OptEx,$28.02,12500,2500,-125%,"+$350,275",-3.0,5.0,-12.0,21.0,MYGN
757,D,2008-09-19 16:50:45,2008-09-19,MYGN,Wilson Linda S,Dir,S - Sale+OE,$65.81,-12500,2500,-83%,"-$822,575",-3.0,5.0,-12.0,21.0,MYGN
758,DM,2008-09-19 16:47:00,2008-09-17,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,10500,72924,+17%,"+$53,813",-3.0,5.0,-12.0,21.0,MYGN
759,D,2008-09-19 16:47:00,2008-09-17,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$66.49,-500,72924,-1%,"-$33,245",-3.0,5.0,-12.0,21.0,MYGN
760,D,2008-09-17 16:41:57,2008-09-17,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$12.54,32380,53121,+156%,"+$406,045",-2.0,-2.0,-15.0,27.0,MYGN
761,D,2008-09-17 16:41:57,2008-09-17,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$66.08,-32380,53121,-38%,"-$2,139,648",-2.0,-2.0,-15.0,27.0,MYGN
762,,2008-09-17 16:39:47,2008-09-16,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$66.00,-19500,516375,-4%,"-$1,287,000",-2.0,-2.0,-15.0,27.0,MYGN
763,D,2008-09-11 16:13:36,2008-09-09,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$15.28,3000,9081,+49%,"+$45,840",-1.0,-3.0,-13.0,25.0,MYGN
764,D,2008-09-08 17:24:43,2008-09-08,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$29.65,28447,9001,-146%,"+$843,505",-2.0,1.0,-8.0,21.0,MYGN
765,D,2008-09-08 17:24:43,2008-09-08,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$64.04,-28447,9001,-76%,"-$1,821,624",-2.0,1.0,-8.0,21.0,MYGN
766,D,2008-09-08 16:31:01,2008-09-05,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$25.74,10000,0,-100%,"+$257,350",-2.0,1.0,-8.0,21.0,MYGN
767,D,2008-09-08 16:31:01,2008-09-05,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$63.31,-10000,0,-100%,"-$633,100",-2.0,1.0,-8.0,21.0,MYGN
768,DM,2008-09-08 16:29:42,2008-09-04,MYGN,Langer Dennis,Dir,M - OptEx,$21.49,10000,0,-100%,"+$214,900",-2.0,1.0,-8.0,21.0,MYGN
769,DM,2008-09-08 16:29:42,2008-09-04,MYGN,Langer Dennis,Dir,S - Sale+OE,$64.78,-10000,0,-100%,"-$647,753",-2.0,1.0,-8.0,21.0,MYGN
770,,2008-09-05 16:37:16,2008-09-03,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-6900,535875,-1%,-$0,1.0,4.0,-3.0,22.0,MYGN
771,,2008-09-05 16:37:16,2008-09-03,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$68.51,-500,535875,0%,"-$34,257",1.0,4.0,-3.0,22.0,MYGN
772,DM,2008-09-05 16:35:24,2008-09-03,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$16.61,26714,13214,-198%,"+$443,734",1.0,4.0,-3.0,22.0,MYGN
773,D,2008-09-05 16:35:24,2008-09-03,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$67.07,-20000,13214,-60%,"-$1,341,482",1.0,4.0,-3.0,22.0,MYGN
774,DM,2008-09-03 17:10:40,2008-08-29,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$10.75,25725,137596,+23%,"+$276,489",-3.0,-4.0,-1.0,20.0,MYGN
775,D,2008-09-03 17:10:40,2008-08-29,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$68.07,-15998,137596,-10%,"-$1,088,926",-3.0,-4.0,-1.0,20.0,MYGN
776,D,2008-09-03 17:09:11,2008-08-29,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$17.86,11198,11274,>999%,"+$199,996",-3.0,-4.0,-1.0,20.0,MYGN
777,D,2008-09-03 17:09:11,2008-08-29,MYGN,Marsh Richard M,"VP, GC",S - Sale+OE,$68.26,-11198,11274,-50%,"-$764,353",-3.0,-4.0,-1.0,20.0,MYGN
778,D,2008-09-03 17:07:33,2008-08-29,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$18.98,18000,6081,-151%,"+$341,610",-3.0,-4.0,-1.0,20.0,MYGN
779,D,2008-09-03 17:07:33,2008-08-29,MYGN,Capone Mark Christopher,"COO, MGL",S - Sale+OE,$67.93,-18000,6081,-75%,"-$1,222,812",-3.0,-4.0,-1.0,20.0,MYGN
780,D,2008-08-27 17:11:01,2008-08-25,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,27464,62924,+77%,"+$140,753",1.0,-1.0,2.0,22.0,MYGN
781,D,2008-08-27 17:11:01,2008-08-25,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$65.03,-27464,62924,-30%,"-$1,785,951",1.0,-1.0,2.0,22.0,MYGN
782,D,2008-08-27 17:09:18,2008-08-27,MYGN,Harrison Robert Gardner,CIO,M - OptEx,$12.61,4085,810,-125%,"+$51,516",1.0,-1.0,2.0,22.0,MYGN
783,D,2008-08-27 17:09:18,2008-08-27,MYGN,Harrison Robert Gardner,CIO,S - Sale+OE,$65.90,-4085,810,-83%,"-$269,202",1.0,-1.0,2.0,22.0,MYGN
784,D,2008-05-20 15:12:40,2008-05-20,MYGN,Wilson Linda S,Dir,G - Gift,$0.00,-50,2500,-2%,-$0,1.0,8.0,6.0,43.0,MYGN
785,D,2008-05-20 15:12:40,2008-05-19,MYGN,Wilson Linda S,Dir,M - OptEx,$29.98,50,2500,+2%,"+$1,499",1.0,8.0,6.0,43.0,MYGN
786,D,2008-04-16 17:23:04,2008-04-14,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$14.81,3500,6500,+117%,"+$51,835",-2.0,-3.0,2.0,41.0,MYGN
787,D,2008-03-20 17:07:42,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,2000,542998,0%,"+$18,625",3.0,12.0,14.0,77.0,MYGN
788,D,2008-03-20 17:07:42,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$34.90,-2000,542998,0%,"-$69,804",3.0,12.0,14.0,77.0,MYGN
789,,2008-03-20 17:07:31,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,12568,252565,+5%,"+$117,040",3.0,12.0,14.0,77.0,MYGN
790,,2008-03-20 17:07:31,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$34.98,-12568,252565,-5%,"-$439,680",3.0,12.0,14.0,77.0,MYGN
791,,2008-03-20 17:07:22,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,5432,252565,+2%,"+$50,586",3.0,12.0,14.0,77.0,MYGN
792,,2008-03-20 17:07:22,2008-03-20,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$35.23,-5432,252565,-2%,"-$191,364",3.0,12.0,14.0,77.0,MYGN
793,D,2008-03-12 14:06:37,2008-03-10,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$14.81,3000,3000,New,"+$44,430",0.0,1.0,18.0,79.0,MYGN
794,D,2008-03-12 14:04:26,2008-03-10,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,10000,62618,+19%,"+$51,250",0.0,1.0,18.0,79.0,MYGN
795,D,2008-03-12 13:30:57,2008-03-10,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$25.06,2462,124374,+2%,"+$61,704",0.0,1.0,18.0,79.0,MYGN
796,D,2008-03-05 17:25:16,2008-03-04,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$11.50,8693,8864,>999%,"+$100,007",-3.0,-5.0,9.0,84.0,MYGN
797,D,2008-02-29 19:00:25,2007-12-07,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-8250,121912,-6%,-$0,0.0,-2.0,9.0,80.0,MYGN
798,D,2008-02-29 18:58:16,2007-12-10,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-10000,517998,-2%,-$0,0.0,-2.0,9.0,80.0,MYGN
799,D,2008-02-29 18:49:38,2007-12-10,MYGN,Marsh Richard M,"VP, GC",G - Gift,$0.00,-824,4496,-15%,-$0,0.0,-2.0,9.0,80.0,MYGN
800,D,2008-02-14 13:19:34,2008-02-12,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$20.56,6526,11846,+123%,"+$134,175",0.0,-4.0,-7.0,75.0,MYGN
801,D,2008-02-07 16:42:26,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,800,552998,0%,"+$7,450",1.0,-2.0,-8.0,66.0,MYGN
802,D,2008-02-07 16:42:26,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$38.75,-800,552998,0%,"-$31,000",1.0,-2.0,-8.0,66.0,MYGN
803,,2008-02-07 16:42:13,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,20500,262565,+8%,"+$190,906",1.0,-2.0,-8.0,66.0,MYGN
804,,2008-02-07 16:42:13,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$38.92,-20500,262565,-7%,"-$797,796",1.0,-2.0,-8.0,66.0,MYGN
805,,2008-02-07 16:41:56,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,3700,262565,+1%,"+$34,456",1.0,-2.0,-8.0,66.0,MYGN
806,,2008-02-07 16:41:56,2008-02-07,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$39.54,-3700,262565,-1%,"-$146,283",1.0,-2.0,-8.0,66.0,MYGN
807,D,2008-02-04 13:19:36,2008-02-01,MYGN,Evans James S,CFO,M - OptEx,$5.13,6000,14719,+69%,"+$30,750",2.0,-5.0,-12.0,58.0,MYGN
808,D,2008-01-30 18:27:38,2008-01-30,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$9.31,25000,552998,+5%,"+$232,813",0.0,-3.0,-13.0,46.0,MYGN
809,D,2008-01-28 16:55:32,2008-01-25,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$7.03,9322,53121,+21%,"+$65,543",1.0,-1.0,-12.0,52.0,MYGN
810,,2008-01-04 13:07:02,2007-12-07,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale,$50.43,-1692,1171,-59%,"-$85,319",-2.0,7.0,-6.0,16.0,MYGN
811,DM,2007-12-21 11:28:47,2007-12-19,MYGN,Langer Dennis,Dir,M - OptEx,$18.37,30000,0,-100%,"+$550,950",0.0,-3.0,-13.0,-1.0,MYGN
812,DM,2007-12-21 11:28:47,2007-12-19,MYGN,Langer Dennis,Dir,S - Sale+OE,$47.57,-30000,0,-100%,"-$1,426,987",0.0,-3.0,-13.0,-1.0,MYGN
813,D,2007-12-20 17:27:03,2007-12-20,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,G - Gift,$0.00,-6916,43799,-14%,-$0,0.0,-3.0,-11.0,3.0,MYGN
814,D,2007-12-20 17:27:03,2007-12-20,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$7.03,4900,43799,+13%,"+$34,452",0.0,-3.0,-11.0,3.0,MYGN
815,,2007-12-19 12:09:20,2007-12-07,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale,$51.00,-1000,1659,-38%,"-$51,000",4.0,6.0,-3.0,10.0,MYGN
816,,2007-12-10 16:40:57,2007-12-06,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$50.44,-27000,527998,-5%,"-$1,361,895",-3.0,-7.0,-8.0,-8.0,MYGN
817,,2007-12-05 19:49:29,2007-12-04,MYGN,Laslie W Wayne,"COO, MPI",S - Sale,$48.30,-1122,2108,-35%,"-$54,193",5.0,-1.0,-8.0,-2.0,MYGN
818,D,2007-12-04 17:29:00,2007-11-30,MYGN,Wilson Linda S,Dir,M - OptEx,$10.84,23900,2500,-112%,"+$258,969",2.0,4.0,-5.0,1.0,MYGN
819,D,2007-12-04 17:29:00,2007-11-30,MYGN,Wilson Linda S,Dir,S - Sale+OE,$48.17,-25000,2500,-91%,"-$1,204,258",2.0,4.0,-5.0,1.0,MYGN
820,D,2007-12-04 17:24:19,2007-11-30,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,5000,52236,+11%,"+$25,625",2.0,4.0,-5.0,1.0,MYGN
821,D,2007-11-26 11:27:01,2007-11-21,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$20.56,1600,5239,+44%,"+$32,896",-1.0,3.0,3.0,6.0,MYGN
822,D,2007-11-06 18:42:25,2007-11-05,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$17.86,5038,0,-100%,"+$89,979",-7.0,-9.0,-8.0,-24.0,MYGN
823,D,2007-11-06 18:42:25,2007-11-05,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$52.97,-5038,0,-100%,"-$266,866",-7.0,-9.0,-8.0,-24.0,MYGN
824,,2007-11-06 18:42:10,2007-11-05,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$19.29,29962,0,-100%,"+$577,871",-7.0,-9.0,-8.0,-24.0,MYGN
825,,2007-11-06 18:42:10,2007-11-05,MYGN,Gilbert Walter Phd,Dir,S - Sale,$52.92,-29962,0,-100%,"-$1,585,639",-7.0,-9.0,-8.0,-24.0,MYGN
826,D,2007-10-23 19:04:09,2007-10-22,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$20.56,1600,3639,+78%,"+$32,896",-1.0,5.0,-12.0,-21.0,MYGN
827,A,2007-10-16 19:38:37,2007-10-05,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale,$57.15,-500,0,-100%,"-$28,575",-3.0,-5.0,-11.0,-23.0,MYGN
828,,2007-10-16 16:56:28,2007-10-15,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale,$55.67,-84,2488,-3%,"-$4,677",-3.0,-5.0,-11.0,-23.0,MYGN
829,,2007-10-16 16:56:15,2007-10-15,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale,$55.33,-1728,2572,-40%,"-$95,613",-3.0,-5.0,-11.0,-23.0,MYGN
830,,2007-10-16 16:55:38,2007-10-15,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale,$54.91,-3074,4300,-42%,"-$168,788",-3.0,-5.0,-11.0,-23.0,MYGN
831,,2007-10-16 16:53:49,2007-10-15,MYGN,Evans James S,VP Finance,S - Sale,$54.98,-6555,8354,-44%,"-$360,372",-3.0,-5.0,-11.0,-23.0,MYGN
832,,2007-10-16 16:53:48,2007-10-15,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$55.31,-20000,130162,-13%,"-$1,106,163",-3.0,-5.0,-11.0,-23.0,MYGN
833,D,2007-10-16 16:51:26,2007-10-15,MYGN,Moyes Jay M,CFO,M - OptEx,$12.54,10036,25682,+64%,"+$125,851",-3.0,-5.0,-11.0,-23.0,MYGN
834,D,2007-10-16 16:51:26,2007-10-15,MYGN,Moyes Jay M,CFO,S - Sale+OE,$55.11,-10036,25682,-28%,"-$553,125",-3.0,-5.0,-11.0,-23.0,MYGN
835,,2007-10-16 16:51:11,2007-10-15,MYGN,Moyes Jay M,CFO,M - OptEx,$12.54,4677,25282,+23%,"+$58,650",-3.0,-5.0,-11.0,-23.0,MYGN
836,,2007-10-16 16:51:11,2007-10-15,MYGN,Moyes Jay M,CFO,S - Sale,$55.50,-4677,25282,-16%,"-$259,581",-3.0,-5.0,-11.0,-23.0,MYGN
837,,2007-10-16 16:51:03,2007-10-15,MYGN,Moyes Jay M,CFO,M - OptEx,$12.54,5931,25282,+31%,"+$74,375",-3.0,-5.0,-11.0,-23.0,MYGN
838,,2007-10-16 16:51:03,2007-10-15,MYGN,Moyes Jay M,CFO,S - Sale,$55.20,-5931,25282,-19%,"-$327,375",-3.0,-5.0,-11.0,-23.0,MYGN
839,,2007-10-16 16:50:54,2007-10-15,MYGN,Moyes Jay M,CFO,M - OptEx,$12.54,9866,25282,+64%,"+$123,720",-3.0,-5.0,-11.0,-23.0,MYGN
840,,2007-10-16 16:50:54,2007-10-15,MYGN,Moyes Jay M,CFO,S - Sale,$55.05,-9866,25282,-28%,"-$543,118",-3.0,-5.0,-11.0,-23.0,MYGN
841,,2007-10-16 16:50:33,2007-10-15,MYGN,Moyes Jay M,CFO,M - OptEx,$12.54,9010,25282,+55%,"+$112,985",-3.0,-5.0,-11.0,-23.0,MYGN
842,,2007-10-16 16:50:33,2007-10-15,MYGN,Moyes Jay M,CFO,S - Sale,$54.75,-9010,25282,-26%,"-$493,330",-3.0,-5.0,-11.0,-23.0,MYGN
843,D,2007-10-15 17:54:57,2007-10-11,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$19.50,10000,3067,-144%,"+$195,000",-1.0,-8.0,-13.0,-25.0,MYGN
844,D,2007-10-15 17:54:57,2007-10-11,MYGN,Laslie W Wayne,"COO, MPI",S - Sale+OE,$57.26,-10000,3067,-77%,"-$572,631",-1.0,-8.0,-13.0,-25.0,MYGN
845,D,2007-10-09 17:30:42,2007-10-05,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$13.39,10000,0,-100%,"+$133,913",0.0,-5.0,-9.0,-30.0,MYGN
846,D,2007-10-09 17:30:42,2007-10-05,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$79.29,-10000,0,-100%,"-$792,897",0.0,-5.0,-9.0,-30.0,MYGN
847,D,2007-09-28 14:16:41,2007-09-27,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$14.81,10036,0,-100%,"+$148,633",0.0,7.0,1.0,-23.0,MYGN
848,D,2007-09-28 14:16:41,2007-09-27,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$52.00,-10036,0,-100%,"-$521,876",0.0,7.0,1.0,-23.0,MYGN
849,DM,2007-09-27 16:18:20,2007-09-25,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$4.78,28000,45815,+157%,"+$133,868",0.0,6.0,-1.0,-23.0,MYGN
850,DM,2007-09-27 16:18:20,2007-09-25,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$50.00,-28000,45815,-38%,"-$1,400,000",0.0,6.0,-1.0,-23.0,MYGN
851,D,2007-09-27 16:15:22,2007-09-25,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,20000,47236,+73%,"+$102,500",0.0,6.0,-1.0,-23.0,MYGN
852,D,2007-09-27 16:15:22,2007-09-25,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$50.00,-20000,47236,-30%,"-$1,000,000",0.0,6.0,-1.0,-23.0,MYGN
853,DM,2007-09-27 16:11:52,2007-09-25,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$12.54,12500,2039,-119%,"+$156,750",0.0,6.0,-1.0,-23.0,MYGN
854,DM,2007-09-27 16:11:52,2007-09-25,MYGN,Marsh Richard M,"VP, GC",S - Sale+OE,$50.00,-12500,2039,-86%,"-$625,000",0.0,6.0,-1.0,-23.0,MYGN
855,D,2007-09-14 19:08:54,2007-09-13,MYGN,Moyes Jay M,CFO,M - OptEx,$10.74,471,25682,+2%,"+$5,059",-2.0,-2.0,16.0,-24.0,MYGN
856,D,2007-09-14 19:08:54,2007-09-13,MYGN,Moyes Jay M,CFO,S - Sale+OE,$47.22,-471,25682,-2%,"-$22,241",-2.0,-2.0,16.0,-24.0,MYGN
857,,2007-09-14 19:08:39,2007-09-13,MYGN,Moyes Jay M,CFO,M - OptEx,$6.86,14481,25282,+134%,"+$99,391",-2.0,-2.0,16.0,-24.0,MYGN
858,,2007-09-14 19:08:39,2007-09-13,MYGN,Moyes Jay M,CFO,S - Sale,$47.30,-14481,25282,-36%,"-$684,878",-2.0,-2.0,16.0,-24.0,MYGN
859,,2007-09-14 19:08:23,2007-09-13,MYGN,Moyes Jay M,CFO,M - OptEx,$7.02,12233,25282,+94%,"+$85,897",-2.0,-2.0,16.0,-24.0,MYGN
860,,2007-09-14 19:08:23,2007-09-13,MYGN,Moyes Jay M,CFO,S - Sale,$47.33,-12233,25282,-33%,"-$578,951",-2.0,-2.0,16.0,-24.0,MYGN
861,,2007-09-14 19:08:09,2007-09-13,MYGN,Moyes Jay M,CFO,M - OptEx,$10.16,28196,25282,-968%,"+$286,336",-2.0,-2.0,16.0,-24.0,MYGN
862,,2007-09-14 19:08:09,2007-09-13,MYGN,Moyes Jay M,CFO,S - Sale,$47.21,-28196,25282,-53%,"-$1,331,269",-2.0,-2.0,16.0,-24.0,MYGN
863,M,2007-09-14 19:07:47,2007-09-12,MYGN,Moyes Jay M,CFO,M - OptEx,$6.93,24897,25282,>999%,"+$172,659",-2.0,-2.0,16.0,-24.0,MYGN
864,M,2007-09-14 19:07:47,2007-09-12,MYGN,Moyes Jay M,CFO,S - Sale,$47.24,-24897,25282,-50%,"-$1,176,025",-2.0,-2.0,16.0,-24.0,MYGN
865,D,2007-09-14 17:44:29,2007-09-12,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$9.31,10000,150162,+7%,"+$93,125",-2.0,-2.0,16.0,-24.0,MYGN
866,D,2007-09-14 17:44:29,2007-09-12,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$47.18,-10000,150162,-6%,"-$471,822",-2.0,-2.0,16.0,-24.0,MYGN
867,,2007-09-14 17:16:38,2007-09-13,MYGN,Evans James S,VP Finance,S - Sale,$47.19,-3914,14909,-21%,"-$184,718",-2.0,-2.0,16.0,-24.0,MYGN
868,D,2007-09-14 17:10:27,2007-09-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$9.31,11262,150162,+8%,"+$104,877",-2.0,-2.0,16.0,-24.0,MYGN
869,D,2007-09-14 17:10:27,2007-09-14,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$47.04,-11262,150162,-7%,"-$529,734",-2.0,-2.0,16.0,-24.0,MYGN
870,D,2007-08-09 16:51:55,2007-08-07,MYGN,Laslie W Wayne,"COO, MPI",M - OptEx,$19.50,9000,3067,-152%,"+$175,500",-7.0,-9.0,3.0,-12.0,MYGN
871,D,2007-08-09 16:51:55,2007-08-07,MYGN,Laslie W Wayne,"COO, MPI",S - Sale+OE,$40.25,-9000,3067,-75%,"-$362,250",-7.0,-9.0,3.0,-12.0,MYGN
872,DM,2007-08-09 16:48:32,2007-08-07,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$14.81,25000,0,-100%,"+$370,250",-7.0,-9.0,3.0,-12.0,MYGN
873,DM,2007-08-09 16:48:32,2007-08-07,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$44.04,-25000,0,-100%,"-$1,100,924",-7.0,-9.0,3.0,-12.0,MYGN
874,D,2007-08-09 16:20:37,2007-08-07,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$15.28,4773,6081,+365%,"+$72,931",-7.0,-9.0,3.0,-12.0,MYGN
875,D,2007-08-09 16:20:37,2007-08-07,MYGN,Capone Mark Christopher,"COO, MGL",S - Sale+OE,$43.01,-4773,6081,-44%,"-$205,268",-7.0,-9.0,3.0,-12.0,MYGN
876,,2007-08-06 18:08:44,2007-08-06,MYGN,Marsh Richard M,"VP, GC",S - Sale,$40.00,-579,2039,-22%,"-$23,160",8.0,4.0,12.0,7.0,MYGN
877,,2007-07-18 16:55:31,2007-07-16,MYGN,Marsh Richard M,"VP, GC",S - Sale,$40.00,-5581,2618,-68%,"-$223,240",-1.0,-2.0,2.0,19.0,MYGN
878,,2007-07-09 17:17:44,2007-07-06,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-2000,583469,0%,-$0,1.0,2.0,3.0,16.0,MYGN
879,,2007-06-18 17:51:25,2007-06-18,MYGN,Marsh Richard M,"VP, GC",S - Sale,$37.78,-6000,8199,-42%,"-$226,666",-1.0,-5.0,3.0,21.0,MYGN
880,,2007-06-18 17:46:47,2007-06-15,MYGN,Moyes Jay M,CFO,S - Sale,$37.73,-1500,25682,-6%,"-$56,595",-1.0,-5.0,3.0,21.0,MYGN
881,D,2007-06-08 18:27:03,2007-06-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$13.56,20000,583469,+4%,"+$271,250",1.0,1.0,5.0,33.0,MYGN
882,D,2007-06-01 17:47:02,2007-05-31,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$13.56,30000,562703,+6%,"+$406,875",-2.0,-3.0,-2.0,29.0,MYGN
883,D,2007-06-01 17:47:02,2007-05-31,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$38.29,-30000,562703,-5%,"-$1,148,622",-2.0,-3.0,-2.0,29.0,MYGN
884,D,2007-05-23 17:23:31,2007-05-23,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,10000,46785,+27%,"+$51,250",-3.0,-2.0,-8.0,13.0,MYGN
885,D,2007-05-23 17:23:31,2007-05-23,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$40.00,-10000,46785,-18%,"-$400,000",-3.0,-2.0,-8.0,13.0,MYGN
886,D,2007-05-09 10:59:49,2007-05-09,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$10.70,30000,0,-100%,"+$321,113",-1.0,-3.0,-5.0,37.0,MYGN
887,D,2007-05-09 10:59:49,2007-05-09,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$38.05,-30000,0,-100%,"-$1,141,608",-1.0,-3.0,-5.0,37.0,MYGN
888,D,2007-05-08 14:51:26,2007-05-08,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$13.56,30000,562703,+6%,"+$406,875",-1.0,-4.0,-3.0,37.0,MYGN
889,D,2007-05-08 14:51:26,2007-05-08,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$38.06,-30000,562703,-5%,"-$1,141,776",-1.0,-4.0,-3.0,37.0,MYGN
890,,2007-05-08 11:10:57,2007-05-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-8675,163639,-5%,-$0,-1.0,-4.0,-3.0,37.0,MYGN
891,,2007-05-08 11:10:57,2007-05-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$39.38,-20000,163639,-11%,"-$787,680",-1.0,-4.0,-3.0,37.0,MYGN
892,D,2007-05-04 16:47:14,2007-05-03,MYGN,Hayes Arthur Hull Jr,Dir,M - OptEx,$13.00,15000,0,-100%,"+$195,000",-2.0,-6.0,-6.0,40.0,MYGN
893,D,2007-05-04 16:47:14,2007-05-03,MYGN,Hayes Arthur Hull Jr,Dir,S - Sale+OE,$39.71,-15000,0,-100%,"-$595,710",-2.0,-6.0,-6.0,40.0,MYGN
894,D,2007-05-04 16:46:18,2007-05-03,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$17.40,84151,7374,-110%,"+$1,464,571",-2.0,-6.0,-6.0,40.0,MYGN
895,D,2007-05-04 16:46:18,2007-05-03,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$39.74,-84151,7374,-92%,"-$3,344,413",-2.0,-6.0,-6.0,40.0,MYGN
896,,2007-05-03 16:45:08,2007-04-27,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-555,192314,0%,-$0,0.0,-4.0,-4.0,37.0,MYGN
897,M,2007-05-03 16:45:08,2007-05-01,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$38.00,-10000,192314,-5%,"-$380,000",0.0,-4.0,-4.0,37.0,MYGN
898,,2007-05-01 11:29:14,2007-05-01,MYGN,Marsh Richard M,"VP, GC",S - Sale,$37.50,-3991,13477,-23%,"-$149,663",2.0,7.0,7.0,43.0,MYGN
899,D,2007-05-01 11:23:24,2007-05-01,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$12.54,8750,0,-100%,"+$109,725",2.0,7.0,7.0,43.0,MYGN
900,D,2007-05-01 11:23:24,2007-05-01,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$37.00,-8750,0,-100%,"-$323,750",2.0,7.0,7.0,43.0,MYGN
901,,2007-04-16 18:26:16,2007-04-16,MYGN,Marsh Richard M,"VP, GC",S - Sale,$36.08,-5000,17468,-22%,"-$180,388",1.0,-1.0,3.0,53.0,MYGN
902,,2007-03-30 11:04:38,2007-03-27,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-200,562703,0%,-$0,1.0,5.0,7.0,53.0,MYGN
903,D,2007-03-26 15:54:58,2007-03-23,MYGN,Capone Mark Christopher,"COO, MGL",M - OptEx,$13.35,5400,6081,+793%,"+$72,102",1.0,-1.0,2.0,34.0,MYGN
904,,2007-03-15 16:34:50,2007-03-14,MYGN,Marsh Richard M,"VP, GC",G - Gift,$0.00,-500,22468,-2%,-$0,0.0,6.0,11.0,46.0,MYGN
905,D,2007-03-15 16:32:23,2007-03-13,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$10.93,16725,7374,-179%,"+$182,735",0.0,6.0,11.0,46.0,MYGN
906,D,2007-03-15 16:32:23,2007-03-13,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$33.28,-16725,7374,-69%,"-$556,541",0.0,6.0,11.0,46.0,MYGN
907,,2007-03-14 18:13:37,2007-03-12,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale,$33.81,-5000,562903,-1%,"-$169,050",-1.0,3.0,9.0,43.0,MYGN
908,D,2007-03-07 16:34:36,2007-03-07,MYGN,Wilson Linda S,Dir,M - OptEx,$10.19,2500,3600,+227%,"+$25,469",2.0,-1.0,7.0,34.0,MYGN
909,D,2007-02-08 18:06:03,2007-02-06,MYGN,Evans James S,VP Finance,M - OptEx,$5.13,5626,18400,+44%,"+$28,833",1.0,-3.0,-7.0,23.0,MYGN
910,D,2007-02-08 18:06:03,2007-02-06,MYGN,Evans James S,VP Finance,S - Sale+OE,$37.00,-5626,18400,-23%,"-$208,162",1.0,-3.0,-7.0,23.0,MYGN
911,D,2007-01-16 16:28:35,2007-01-12,MYGN,Simon S George,VP Business Development,M - OptEx,$11.91,5000,2278,-184%,"+$59,552",2.0,0.0,0.0,11.0,MYGN
912,D,2007-01-16 16:28:35,2007-01-12,MYGN,Simon S George,VP Business Development,S - Sale+OE,$35.00,-5000,2278,-69%,"-$175,018",2.0,0.0,0.0,11.0,MYGN
913,D,2007-01-16 12:03:58,2007-01-16,MYGN,Simon S George,VP Business Development,M - OptEx,$12.54,5000,2278,-184%,"+$62,700",0.0,1.0,0.0,11.0,MYGN
914,D,2007-01-16 12:03:58,2007-01-16,MYGN,Simon S George,VP Business Development,S - Sale+OE,$35.09,-5000,2278,-69%,"-$175,439",0.0,1.0,0.0,11.0,MYGN
915,,2007-01-16 11:59:58,2007-01-12,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$35.00,-10000,202869,-5%,"-$350,000",0.0,1.0,0.0,11.0,MYGN
916,D,2007-01-11 18:10:55,2007-01-11,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$12.54,5000,0,-100%,"+$62,700",3.0,3.0,6.0,17.0,MYGN
917,D,2007-01-11 18:10:55,2007-01-11,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$34.00,-5000,0,-100%,"-$170,000",3.0,3.0,6.0,17.0,MYGN
918,,2007-01-11 18:08:53,2007-01-10,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$33.00,-10000,212869,-4%,"-$330,000",3.0,3.0,6.0,17.0,MYGN
919,D,2007-01-11 17:29:18,2007-01-09,MYGN,Moyes Jay M,CFO,M - OptEx,$13.56,8156,26724,+44%,"+$110,616",3.0,3.0,6.0,17.0,MYGN
920,D,2007-01-11 17:29:18,2007-01-09,MYGN,Moyes Jay M,CFO,S - Sale+OE,$32.50,-8156,26724,-23%,"-$265,070",3.0,3.0,6.0,17.0,MYGN
921,D,2007-01-03 15:45:35,2007-01-03,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,5000,46785,+12%,"+$25,625",0.0,4.0,14.0,22.0,MYGN
922,D,2007-01-03 15:45:35,2007-01-03,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$32.00,-5000,46785,-10%,"-$160,000",0.0,4.0,14.0,22.0,MYGN
923,D,2007-01-03 15:38:26,2007-01-03,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$4.78,5000,7374,+211%,"+$23,905",0.0,4.0,14.0,22.0,MYGN
924,D,2007-01-03 15:38:26,2007-01-03,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$32.00,-5000,7374,-40%,"-$160,000",0.0,4.0,14.0,22.0,MYGN
925,M,2006-12-14 18:09:05,2006-11-07,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-9285,222869,-4%,-$0,-1.0,1.0,16.0,24.0,MYGN
926,,2006-12-14 18:09:05,2006-12-13,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$30.90,-20000,222869,-8%,"-$618,000",-1.0,1.0,16.0,24.0,MYGN
927,DM,2006-11-20 13:54:03,2006-11-16,MYGN,Moyes Jay M,CFO,M - OptEx,$13.56,8156,26278,+45%,"+$110,616",0.0,-1.0,3.0,32.0,MYGN
928,DM,2006-11-20 13:54:03,2006-11-16,MYGN,Moyes Jay M,CFO,S - Sale+OE,$30.00,-8156,26278,-24%,"-$244,682",0.0,-1.0,3.0,32.0,MYGN
929,D,2006-11-15 17:02:05,2006-11-15,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$12.54,4176,0,-100%,"+$52,367",1.0,2.0,5.0,29.0,MYGN
930,D,2006-11-15 17:02:05,2006-11-15,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$29.00,-4176,0,-100%,"-$121,104",1.0,2.0,5.0,29.0,MYGN
931,M,2006-11-13 10:38:00,2006-11-09,MYGN,Gilbert Walter Phd,Dir,S - Sale,$26.99,-35940,0,-100%,"-$969,879",3.0,8.0,11.0,36.0,MYGN
932,D,2006-11-08 12:06:25,2006-11-07,MYGN,Lanchbury Jerry S,Exec VP - Research,M - OptEx,$12.54,824,0,-100%,"+$10,333",-5.0,2.0,8.0,32.0,MYGN
933,D,2006-11-08 12:06:25,2006-11-07,MYGN,Lanchbury Jerry S,Exec VP - Research,S - Sale+OE,$29.00,-824,0,-100%,"-$23,896",-5.0,2.0,8.0,32.0,MYGN
934,D,2006-10-19 20:03:27,2006-10-19,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$4.92,8588,7145,-595%,"+$42,294",-2.0,-4.0,6.0,28.0,MYGN
935,D,2006-10-19 20:03:27,2006-10-19,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$28.00,-8588,7145,-55%,"-$240,464",-2.0,-4.0,6.0,28.0,MYGN
936,,2006-10-18 11:54:48,2006-10-18,MYGN,Moyes Jay M,CFO,S - Sale,$27.08,-5000,26278,-16%,"-$135,398",1.0,1.0,11.0,34.0,MYGN
937,D,2006-08-31 12:40:25,2006-08-30,MYGN,Hayes Arthur Hull Jr,Dir,M - OptEx,$14.13,15000,0,-100%,"+$211,875",0.0,-5.0,-2.0,30.0,MYGN
938,D,2006-08-31 12:40:25,2006-08-30,MYGN,Hayes Arthur Hull Jr,Dir,S - Sale+OE,$25.13,-15000,0,-100%,"-$376,936",0.0,-5.0,-2.0,30.0,MYGN
939,D,2006-06-14 17:06:12,2006-06-14,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$17.86,11198,22475,+99%,"+$199,996",4.0,-1.0,-1.0,37.0,MYGN
940,D,2006-06-13 18:36:11,2006-06-13,MYGN,Moyes Jay M,CFO,M - OptEx,$12.38,15444,30300,+104%,"+$191,120",1.0,0.0,5.0,37.0,MYGN
941,D,2006-06-07 12:47:58,2006-06-07,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$12.38,27000,572131,+5%,"+$334,125",1.0,-9.0,0.0,23.0,MYGN
942,D,2006-06-07 12:47:58,2006-06-07,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$24.93,-27000,572131,-5%,"-$673,105",1.0,-9.0,0.0,23.0,MYGN
943,D,2006-05-09 12:20:19,2006-05-08,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$12.38,21436,572131,+4%,"+$265,271",-5.0,-6.0,-9.0,-2.0,MYGN
944,D,2006-05-09 12:20:19,2006-05-08,MYGN,Skolnick Mark H,Chief Scientific Officer,S - Sale+OE,$28.00,-21436,572131,-4%,"-$600,225",-5.0,-6.0,-9.0,-2.0,MYGN
945,D,2006-05-05 13:46:50,2006-05-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$13.56,8628,265207,+3%,"+$117,017",1.0,-4.0,-10.0,-6.0,MYGN
946,D,2006-05-05 13:46:50,2006-05-04,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale+OE,$28.00,-8628,265207,-3%,"-$241,584",1.0,-4.0,-10.0,-6.0,MYGN
947,D,2006-05-05 13:44:34,2006-05-05,MYGN,Simon S George,VP Business Development,M - OptEx,$10.74,10000,916,-110%,"+$107,400",-1.0,-4.0,-10.0,-6.0,MYGN
948,D,2006-05-05 13:44:34,2006-05-05,MYGN,Simon S George,VP Business Development,S - Sale+OE,$28.02,-10000,916,-92%,"-$280,164",-1.0,-4.0,-10.0,-6.0,MYGN
949,D,2006-04-27 13:56:25,2006-04-27,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,5000,45645,+12%,"+$25,625",0.0,6.0,-3.0,5.0,MYGN
950,D,2006-04-27 13:56:25,2006-04-27,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$26.01,-5000,45645,-10%,"-$130,050",0.0,6.0,-3.0,5.0,MYGN
951,D,2006-04-17 16:24:06,2006-04-17,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,M - OptEx,$7.03,35556,43720,+436%,"+$249,994",4.0,5.0,6.0,5.0,MYGN
952,D,2006-04-17 16:24:06,2006-04-17,MYGN,Critchfield Gregory C,Pres Myriad Genetic Labs,S - Sale+OE,$24.55,-35556,43720,-45%,"-$872,957",4.0,5.0,6.0,5.0,MYGN
953,D,2006-03-27 14:06:13,2006-03-23,MYGN,Evans James S,VP Finance,M - OptEx,$5.13,1500,17325,+9%,"+$7,688",-2.0,1.0,-1.0,-9.0,MYGN
954,D,2006-03-24 12:34:00,2006-03-23,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$10.83,9230,265207,+4%,"+$99,992",1.0,2.0,0.0,-5.0,MYGN
955,D,2006-03-13 12:19:16,2006-03-13,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$12.54,10000,10453,>999%,"+$125,400",4.0,5.0,-9.0,-9.0,MYGN
956,D,2006-03-13 12:19:16,2006-03-13,MYGN,Marsh Richard M,"VP, GC",S - Sale+OE,$27.55,-10000,10453,-49%,"-$275,524",4.0,5.0,-9.0,-9.0,MYGN
957,D,2006-03-10 19:33:34,2006-03-10,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$12.38,16564,572131,+3%,"+$204,980",3.0,5.0,-8.0,-10.0,MYGN
958,D,2006-03-09 15:58:19,2006-03-08,MYGN,Hayes Arthur Hull Jr,Dir,M - OptEx,$5.69,15000,0,-100%,"+$85,313",1.0,5.0,-5.0,-6.0,MYGN
959,D,2006-03-09 15:58:19,2006-03-08,MYGN,Hayes Arthur Hull Jr,Dir,S - Sale+OE,$25.73,-25000,0,-100%,"-$643,317",1.0,5.0,-5.0,-6.0,MYGN
960,DM,2006-03-09 15:48:03,2006-03-07,MYGN,Gilbert Walter Phd,Dir,M - OptEx,$11.52,55000,35940,-289%,"+$633,438",1.0,5.0,-5.0,-6.0,MYGN
961,DM,2006-03-09 15:48:03,2006-03-07,MYGN,Gilbert Walter Phd,Dir,S - Sale+OE,$25.91,-55000,35940,-60%,"-$1,424,842",1.0,5.0,-5.0,-6.0,MYGN
962,D,2006-02-27 18:20:16,2006-02-27,MYGN,Moyes Jay M,CFO,M - OptEx,$12.38,2900,14856,+24%,"+$35,888",0.0,2.0,1.0,-4.0,MYGN
963,D,2006-02-27 18:20:16,2006-02-27,MYGN,Moyes Jay M,CFO,S - Sale+OE,$25.21,-2900,14856,-16%,"-$73,101",0.0,2.0,1.0,-4.0,MYGN
964,D,2006-02-14 18:56:39,2006-02-10,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$5.13,3588,6854,+110%,"+$18,389",2.0,0.0,15.0,5.0,MYGN
965,D,2006-02-14 18:56:39,2006-02-10,MYGN,Hockett William A III,V. P. of Corp Communications,S - Sale+OE,$25.00,-3588,6854,-34%,"-$89,700",2.0,0.0,15.0,5.0,MYGN
966,,2006-02-14 18:53:00,2006-02-13,MYGN,Meldrum Peter D,"Pres, C.E.O.",S - Sale,$25.00,-10000,255977,-4%,"-$250,000",2.0,0.0,15.0,5.0,MYGN
967,D,2006-02-14 18:52:08,2006-02-10,MYGN,Moyes Jay M,CFO,M - OptEx,$12.38,12544,14856,+543%,"+$155,232",2.0,0.0,15.0,5.0,MYGN
968,D,2006-02-14 18:52:08,2006-02-10,MYGN,Moyes Jay M,CFO,S - Sale+OE,$25.03,-12544,14856,-46%,"-$314,025",2.0,0.0,15.0,5.0,MYGN
969,D,2006-02-14 18:51:18,2006-02-10,MYGN,Simon S George,VP Business Development,M - OptEx,$10.74,5000,916,-122%,"+$53,700",2.0,0.0,15.0,5.0,MYGN
970,D,2006-02-14 18:51:18,2006-02-10,MYGN,Simon S George,VP Business Development,S - Sale+OE,$25.00,-5000,916,-85%,"-$125,000",2.0,0.0,15.0,5.0,MYGN
971,,2005-12-21 12:13:18,2005-12-21,MYGN,Moyes Jay M,CFO,S - Sale,$19.98,-2448,14856,-14%,"-$48,913",3.0,6.0,9.0,18.0,MYGN
972,D,2005-11-07 13:42:11,2005-11-07,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$16.97,350,9491,+4%,"+$5,940",3.0,3.0,6.0,42.0,MYGN
973,M,2005-06-29 16:30:29,2004-12-20,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-15700,264440,-6%,-$0,-3.0,2.0,9.0,29.0,MYGN
974,D,2005-06-20 12:15:39,2005-06-16,MYGN,Marsh Richard M,"VP, GC",M - OptEx,$12.54,7500,9141,+457%,"+$94,050",2.0,2.0,12.0,33.0,MYGN
975,D,2005-06-09 18:39:27,2005-06-09,MYGN,Moyes Jay M,"VP Finance, C.F.O.",M - OptEx,$3.50,5500,16138,+52%,"+$19,250",1.0,-2.0,14.0,28.0,MYGN
976,D,2005-05-18 17:24:09,2005-05-18,MYGN,Hayes Arthur Hull Jr,Dir,M - OptEx,$3.50,10000,10000,New,"+$35,000",0.0,-2.0,-12.0,7.0,MYGN
977,D,2005-04-27 17:51:55,2005-04-27,MYGN,Skolnick Mark H,Chief Scientific Officer,M - OptEx,$4.78,8004,553836,+1%,"+$38,267",-6.0,-7.0,-2.0,26.0,MYGN
978,D,2005-01-14 11:16:20,2005-01-13,MYGN,Simon S George,VP Business Development,M - OptEx,$10.74,2000,0,-100%,"+$21,480",3.0,6.0,-8.0,-27.0,MYGN
979,D,2005-01-14 11:16:20,2005-01-13,MYGN,Simon S George,VP Business Development,S - Sale+OE,$25.12,-2000,0,-100%,"-$50,241",3.0,6.0,-8.0,-27.0,MYGN
980,D,2005-01-14 11:13:48,2005-01-13,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,2024,44172,+5%,"+$10,373",3.0,6.0,-8.0,-27.0,MYGN
981,D,2005-01-14 11:13:48,2005-01-13,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,S - Sale+OE,$25.00,-2024,44172,-4%,"-$50,600",3.0,6.0,-8.0,-27.0,MYGN
982,,2004-11-12 18:10:21,2004-11-12,MYGN,Simon S George,VP Business Development,S - Sale,$20.00,-653,0,-100%,"-$13,060",-1.0,-2.0,14.0,-9.0,MYGN
983,D,2004-09-09 16:54:03,2004-09-07,MYGN,Skolnick Mark H,Chief Scientific Officer,G - Gift,$0.00,-1000,544789,0%,-$0,2.0,2.0,5.0,26.0,MYGN
984,D,2004-08-06 16:16:43,2004-08-05,MYGN,Hobden Adrian N,Pres Myriad Pharmaceuticals,M - OptEx,$5.13,3000,43488,+7%,"+$15,375",-4.0,3.0,28.0,94.0,MYGN
985,D,2004-07-28 18:41:06,2004-07-28,MYGN,Hockett William A III,V. P. of Corp Communications,M - OptEx,$3.50,3172,5864,+118%,"+$11,102",2.0,-2.0,16.0,85.0,MYGN
986,D,2004-07-02 16:47:16,2004-07-02,MYGN,Meldrum Peter D,"Pres, C.E.O.",M - OptEx,$7.38,18739,276548,+7%,"+$138,256",-4.0,-5.0,-7.0,58.0,MYGN
987,D,2004-05-14 17:07:37,2004-05-14,MYGN,Wilson Linda S,Dir,M - OptEx,$10.19,610,1100,+124%,"+$6,214",-1.0,-7.0,-14.0,18.0,MYGN
988,,2004-05-11 17:48:38,2004-05-11,MYGN,Henderson John T,Dir,P - Purchase,$17.03,2000,2000,New,"+$34,060",3.0,-1.0,-15.0,9.0,MYGN
989,,2004-03-02 13:43:30,2004-02-20,MYGN,Meldrum Peter D,"Pres, C.E.O.",G - Gift,$0.00,-5200,257809,-2%,-$0,0.0,2.0,-6.0,-7.0,MYGN
990,,2004-02-06 17:42:37,2004-02-06,MYGN,Attiyeh Robert S,Dir,P - Purchase,$16.65,2000,3000,+200%,"+$33,304",3.0,5.0,4.0,-25.0,MYGN
991,D,2003-11-05 15:07:59,2003-11-05,MYGN,Wilson Linda S,Dir,M - OptEx,$10.19,490,490,New,"+$4,992",3.0,-5.0,6.0,55.0,MYGN
